1st International Congress on Borderline Personality Disorder

Transcription

Plenarvo
rträge
werden si
multan
übersetzt
1st International Congress on
Borderline Personality Disorder
1 – 3 July 2010 // bcc Berliner Congress Center // Berlin
Accredited by the European Council for Continuing Medical Education (EACCME)
Accredited by the Ärztekammer Berlin with 15 CME credits
www.borderline-congress.org
Final Programme
1
Contents
page
3 Welcome Addresses / Grußworte
page
26 Scientific Programme by Day
Thursday, 1 July
10 Congress Organisation
13 Format Descriptions, Topics
and Programme Structure
Friday, 2 July
14 Programme Overview Thursday, 1 July
Saturday, 3 July
16 Programme Overview Friday, 2 July
60 Betroffenen-Diskussionsforum
18 Programme Overview Saturday, 3 July
61 Acknowlegdements
20 Scientific Programme by Topic
62 Congress Information
25 Plenary Sessions
65 The City of Berlin
66 Index of Authors and Chair Persons
Congress Language
The official language of the 1st International
Congress on Borderline Personality Disorder is
English. A selection of sessions, marked with
, will be held in German. Sessions, marked
with , will be held in English. The Opening
Ceremony as well as the Plenary Lectures and
all sessions with
will be translated simulaneously from English into German and viceversa.
Congress Venue
bcc Berliner Congress Center
Alexanderstr. 11, 10178 Berlin, Germany
S-Bahn and Underground station:
Alexanderplatz
Congress President
Professor Martin Bohus, MD
Kongresssprache
Die offizielle Kongresssprache des 1st Internatio
nal Congress on Borderline Personality Disorder
ist Englisch. Eine Auswahl an Veranstaltungen
findet in deutscher Sprache statt und ist ent
sprechend gekennzeichnet: . Englischsprachi
ge Veranstaltungen sind mit
gekennzeichnet.
Die Eröffnungsveranstaltung sowie die Plenarvor
träge und Veranstaltungen, die mit
gekenn
zeichnet sind, werden simultan vom Englischen
ins Deutsche und umgekehrt übersetzt.
Local President and Scientific Contact
Thorsten Kienast, MD
Schön Klinik Hamburg-Eilbek
Department of Psychiatry
Dehnhaide 120, 22081 Hamburg, Germany
Charité Campus Mitte
Charitéplatz 1, 10115 Berlin
Congress and Exhibition Office
Central Institute of Mental Health (CIMH)
J5
68159 Mannheim, Germany
2
CPO HANSER SERVICE GmbH
Paulsborner Str. 44
14193 Berlin, Germany
Phone:+49 – 30 – 300 669-0
Fax: +49 – 30 – 300 669-50
Email: [email protected]
Web: www.borderline-congress.org
Welcome Address
Dear Colleagues and Congress Visitors,
On behalf of the organising committee, I would like
to welcome you to Berlin. The city of Berlin itself
looks back on a long and sometimes painful history
as being “borderline” and yet it has since recovered
very well from these traumatic experiences. What
could be more appropriate then than to organise the
world’s first congress on this topic?
It really is the first time that a congress is taking place with the single
stated aim of discussing the current status of research into borderline
personality disorders. There are good reasons for this: people with borderline personality disorder have spent many years largely ignored by
science, lurking in the “dirty corner” of psychiatry, and subjected to speculative ideas and inadequate treatment methods. The consequences for
those affected and their families have often been disastrous. Fortunately,
however, this is now history. Unlike any other mental disorder, our knowledge about the origin, progress, phenomenology and neurobiology of
borderline personality disorders has multiplied in the last decade. The
treatment possibilities have also improved to such an extent that there are
now several competing, evidence-based treatment concepts available –
optimum conditions in fact. That said, we are certainly far from being
satisfied – only approximately 60 % of patients treated benefit from the
currently established procedures – but we have made a start. All of us
here today understand that only a critical examination of our knowledge
and the continuous exchange of information and ideas between basic researchers, therapy developers, clinical therapists and those affected will
take us forward.
We must take this congress as an impetus for further growth – as we plan
to continue this meeting every two years. The time is ripe to accord those
with borderline personality disorder the position that is rightfully theirs in
the field of psychotherapeutic research and in healthcare provision; not
only to relieve the suffering of those affected and their family members
but to enable them to lead a life worth living.
Our thanks go to all the cooperating specialist associations and sponsors
who have placed their confidence in us as well as to the employees of
CPO HANSER SERVICE, who have capably and proficiently partnered us
in designing the congress.
Prof. Dr. Martin Bohus
Congress President
3
Grußwort
Sehr geehrte Kolleginnen und Kollegen,
liebe Kongressbesucherinnen und Besucher,
im Namen des Organisationskomitees heiße ich Sie
herzlich in Berlin willkommen. Die Stadt Berlin
schaut selbst auf eine lange und manchmal leidvolle
Geschichte als „border-line“ zurück und hat sich mitt
lerweile doch sehr gut von diesen traumatischen Erfahrungen erholt. Was liegt also näher, als den weltweit ersten Kongress zu dieser Thematik in Berlin zu veranstalten?
Es ist tatsächlich das erste Mal, dass ein Kongress stattfindet, dessen er
klärtes und alleiniges Ziel es ist, den derzeitigen Stand der Forschung zur
Borderline-Störung zu diskutieren. Das hat gute Gründe: verbrachte die
Borderline-Störung doch viele Jahre weitgehend unbeachtet von der Wissenschaft in der „Schmuddelecke“ der Psychiatrie und war durchsetzt mit
spekulativen Konzepten und insuffizienten Behandlungsmethoden. Die
Folgen für die Betroffenen und deren Familien waren oft verheerend.
Doch dies ist erfreulicherweise Geschichte. Wie in kaum einem zweiten
psychischen Störungsbild hat sich unser Wissen zu Entstehung, Verlauf,
Phänomenologie und Neurobiologie der Borderline-Störung in der letzten Dekade vervielfacht. Auch die Möglichkeiten der Behandlung haben
sich so weit verbessert, dass gleich mehrere evidenz-basierte Behandlungskonzepte vorliegen und konkurrieren – optimale Bedingungen also.
Sicherlich sind wir weit davon entfernt, zufrieden zu sein, – nur etwa
60 % der behandelten Patienten profitieren von den derzeit etablierten
Verfahren – aber ein Anfang ist gemacht. Und wir alle, die wir hier sind,
haben verstanden, dass nur die kritische Überprüfung unseres Wissens
und der kontinuierliche Austausch zwischen Grundlagenforschern, The
rapieentwicklern, klinischen Therapeuten und den Betroffenen uns weiter
voran bringen wird.
Nehmen wir diesen Kongress als ein Signal zum Aufbruch, er wird von
nun an alle zwei Jahre seine Fortsetzung finden. Die Zeit ist reif, der Borderline-Störung den Platz zuzuweisen, den sie im psychotherapeutischen
Forschungsfeld und in der gesundheitspolitischen Versorgung bean
sprucht, um so das Leid der Betroffenen und ihrer Angehörigen zu lindern
und ihnen ein lebenswertes Leben zu ermöglichen.
Unser Dank gilt allen kooperierenden Fachgesellschaften und Sponsoren
die uns ihr Vertrauen geschenkt haben sowie den Mitarbeitern des Unter
nehmens CPO HANSER SERVICE, unserem kompetenten Partner bei der
Gestaltung des Kongresses.
Kongresspräsident
4
Welcome Address
Dear Ladies and Gentlemen
As local organizer and on behalf of the local scientific
committee, I am honoured to welcome you to the
1st International Congress on Borderline Personality
Disorder. The congress gathers leading scientists
and clinicians from all over the world who will present
new and exciting findings. We are convinced that the
various symposia, lectures, practice seminars and
oral presentations will provide valuable insight into present and future
aspects of borderline personality disorder-related research and inspire
many fruitful discussions. We are looking forward to sharing with you this
opportunity to exchange knowledge, ideas, and experiences to work
together towards a better understanding and improved therapy for our
patients.
I would like to thank all those who have contributed to the successful
outcome of the congress, particularly the congress organisation CPO
Hanser Service GmbH.
I do hope that you will enjoy a few pleasant summer days in Berlin. Our
charming metropolis, where “East” meets “West”, has its own flair and
character and is well worth looking at.
Thorsten Kienast, MD, MBA
Local Congress President
5
Grußwort
Liebe Kolleginnen und Kollegen,
herzlich willkommen im Namen unserer Stadt und
des wissenschaftlichen Komittees zu unserem ersten
Internationalen Kongress zu Borderline Persönlich
keitsstörung, der in Berlin stattfinden darf. Wir möch
ten mit diesem Kongress Forschern und Mitarbeitern,
Therapeuten und Co-Therapeuten aller Berufsgruppen, die an der Behandlung von Patienten mit Borderline Persönlichkeitsstörung beteiligt sind, eine hervorragende Möglichkeit
für gegenseitigen Austausch geben. Es ist uns gelungen, national und
international führende Wissenschaftler und Therapeuten aus vielen Berei
chen dieses Forschungsgebietes, von Biologie zu Psychotherapie, von
Epidemiologie zu Ökonomie, für 3 Tage an einem Ort zu versammeln und
Austausch zu schaffen. Wir sind überzeugt, dass die einzelnen Veranstal
tungen wertvolle Einblicke in wissenschaftliche Hintergründe und her
vorragende Trainingsmöglichkeiten für Therapeuten bieten. Die Plenarvortäge werden in die Deutsche Sprache übersetzt.
Auf diesem Kongress feiert auch das Netzwerktreffen „Dialektisch Behaviorale Therapie“ sein 10-jähriges Bestehen. Hierzu möchten wir herzlich
gratulieren. Danken möchte ich an dieser Stelle allen Helferinnen und
Helfern, die diesen Kongress ermöglicht haben. Meinen ganz besonderen
Dank möchte ich dem organisierenden Kongressbüro CPO Hanser
Service aussprechen.
Ich freue mich sehr, Sie in diesem Sommer in unserer wundervollen,
lebenswerten Stadt Berlin begrüßen zu dürfen und wünsche Ihnen ein
herrliches privates Rahmenprogramm.
Dr. Thorsten Kienast, MBA
Lokaler Kongresspräsident
6
Welcome Addresses
Dear Colleagues,
This First International Congress on Borderline Personality Disorder is a milestone in the development
of the BPD concept as a clinically relevant nosological entity in mental health care and research.
I remember well the first Conference on Borderline
Personality Disorder which was organized by the
Dutch Royal Academy of Science 20 years ago. It was a conference of pioneers with international speakers addressing the upcoming concept of the
borderline personality disorder. The BPD conference had an enormous
spinoff for treatment and for research on BPD in the Netherlands. Compar
able developments took place in many countries and many clinicians and
researchers from all over the world contributed to the tremendous growth
of knowledge regarding BPD. This is all the more remarkably, since personality disorders are not regarded as a major psychiatric disorder. In
most countries is it very hard to get funding for PD research and as a results in many countries PD is still a neglected and underdeveloped topic
for treatment and research.
We still have to work further on the emancipation of the Borderline Personality Disorder as a clinically relevant syndrome in order to generate
better research funding, to support all the mental health workers in their
difficult daily work, and to decrease the suffering of our BPD patients.
I hope that this conference with its excellent keynote speakers and outstanding scientific program will inspire you as mental health workers,
researchers, and policymakers to contribute to the further development
and emancipation of Borderline Personlaty Disorder.
Enjoy the congress and I hope you all will have a great time in Berlin.
Dr. Thomas Rinne
Vice-President International Society for the Study of Personality Disorders
(ISSPD)
Founding-President European Society for the Study of Personality Disorders
(ESSPD)
7
Welcome Address
On behalf of the American Psychiatric Association, it
is my pleasure to welcome you to the First International Congress on Borderline Personality Disorder.
BPD is a prevalent, disabling, and complex illness
that is often misunderstood. Too often, treatment for
patients with this disorder is inadequate, insufficient,
or unavailable. New research, however, is clarifying
developmental and neurobiological aspects of BPD,
and randomized controlled trials repeatedly demonstrate that treatment works. This Congress is an invaluable forum for international scientific and clinical collaboration on behalf of patients with
BPD.
John M. Oldham, M. D.
President-Elect, American Psychiatric Association
Dear Colleagues
This first International Congress on Borderline Person
ality Disorder is a major milestone in the advances of
our field, and especially in line with the purpose of
our organization, the International Society for the
Studies of Personality Disorders, ISSPD. This Congress is a significant opportunity to integrate the recent most extensive and multidisciplinary studies of
BPD, and to gather scientists and clinicians from all over the world to an
attractive site in the center of Europe. The initiative of the congress or
ganizers Drs. Bohus and Kienast is commendable, both timely and relevant. On behalf of ISSPD I would like to express our support of this event
and of a very diverse and interesting program outline.
Elsa Ronningstam, Ph. D.
President International Society for the Study of Personality Disorders (ISSPD)
8
Welcome Address
Borderline personality disorder – today a well approved psychiatric diagnosis
– had long been seen by psychoanalysts as a behavior of hardly treatable neurotic patients. Thanks to the psychiatrists Stern and Knight who introduced the
label “borderline” this psychiatric picture finally received a clinical meaning.
Overall, it took decades to integrate the disturbance into the group of personality disorders. Much research was needed to understand the symptoms of this
disorder and its significant heritability to develop selective ways of successful
treatment. Today, with about 2 % of our population suffering from Borderline,
the disease is more common than schizophrenic diseases. About 80 % of the
affected people start psychiatric or psychotherapeutic treatment. Many university hospitals maintain specific borderline wards supervised by well-skilled therapists.
By now, we are well grounded in treating Borderline patients with effective psychotherapy as well
as using psychopharmacology. But why is Borderline so extraordinary to hold an international congress on this topic? Widely known is the enormous impact of the clinical symptoms on patients and
on their affiliates. The diverse phenomenology within the clinical picture is intriguing due to distinct
individual personality components. However, the most important point is the strong influence the
development of diagnosis and effective treatment of Borderline personality disorder had on the
development of psychotherapy within psychiatry. Many studies contributed to the understanding of
Borderline and helped relate it to the Diagnostic and Statistical Manual of Mental Disorders (DSM).
Last but not least: the development of disorder-specific psychotherapeutic treatment models opened
the door for school independent ways of psychotherapeutic treatment in psychiatry. Nevertheless,
more research is needed to investigate Borderline personality disorder’s psychopathology and its
related neurobiology. In addition, the ambulant medical health care for Borderline patients is still
severely insufficient and has to be strongly improved.
Despite the enormous scientific improvements, Borderline personality disorder remains strongly
and unfairly stigmatized. Hence, it is necessary to increase the awareness of Borderline personality
disorder among people suffering from this disorder, their families, medical professionals and the
general public.
The first International Congress on Borderline Personality Disorder is a milestone in a long struggle
for adequate diagnosis, classification and treatment of a long underestimated disease. First of all,
Borderline patients should be credited for this conference to take place. With all their challenging
behavior they have forced the psychiatric community to forge ahead. Secondly, researchers in the
field of psychotherapy like Prof. Marsha Linehan have to be credited for this conference because of
their open-mindedness to search for completely new ways to do psychotherapy. And last but not
least, Prof. Martin Bohus has to be credited for his effort and success in bringing this conference to
Berlin. He already proved to be an excellent organizer on many occasions and he did it again here.
We are very proud to have this conference here in Germany.
Professor Frank Schneider, M. D., Ph. D.
President of the German Association for Psychiatry and Psychotherapy (DGPPN)
9
Congress Organisation
Local President and Scientific Contact
Thorsten Kienast, MD
Schön Klinik Hamburg-Eilbek
Department of Psychiatry
Dehnhaide 120, 22081 Hamburg, Germany
Charité Campus Mitte
Charitéplatz 1, 10115 Berlin
N
10
HIATRIC ASS
YC
O
PS
IO
AT
CI
Scientific Advisory Board
Arnoud Arntz, The Netherlands
Martin Bohus, Germany
Wies van den Bosch, The Netherlands
Unice Chen, USA
John Clarkin, USA
Emil Coccaro, USA
Linda Dimeff, USA
Peter Fonagy, United Kingdom
Alan Fruzzetti, USA
Sabine Herpertz, Germany
Andre Ivanoff, USA
Thorsten Kienast, Germany
Klaus Lieb, Germany
Marsha Linehan, USA
Paul Links, Canada
Tom Lynch, United Kingdom
Cesare Maffei, Italy
Shelley McMain, Canada
Antonia New, USA
Valery Porr, USA
Alexandra Phillipsen, Germany
Babette Renneberg, Germany
Thomas Rinne, The Netherlands
Franz Resch, Germany
Christian Schmahl, Germany
Ulrich Schweiger, Germany
Larry Siever, USA
Kenneth Silk, USA
Regina Steil, Germany
Svenn Torgersen, Norway
Peter Tyrer, United Kingdom
The Congress will be organized in cooperation with
Association for Research in Personality Disorders (ARPD)
Austrian Association for Psychiatry and Psychotherapy (ÖGPP)
Central Institute of Mental Health, Mannheim
(CIMH)
European Psychiatric Association (EPA)
European Society for the Study of Personality
Disorders (ESSPD)
German Association for DBT (Dachverband Dialektisch-Behaviorale Therapie e. V. – DDBT)
German Association for Psychiatry and Psychotherapy (DGPPN)
Gesellschaft zur Erforschung und Therapie von
Persönlichkeitsstörungen (GePs)
International Society for the Study of Personality Disorders (ISSPD)
Swiss Association for Psychiatry and Psychotherapy (SGPP)
World Psychiatric Association (WPA)
WOR
LD
Congress President
Professor Martin Bohus, MD
Central Institute of Mental Health (CIMH)
J5
68159 Mannheim, Germany
ww
or
w. w
panet.
Congress and Exhibition Office
CPO HANSER SERVICE GmbH
Paulsborner Str. 44
Phone: +49 – 30 – 300 669-0
Fax: +49 – 30 – 300 669-50
Web: www.borderline-congress.org
g
Klinik für Psychiatrie und Psychotherapie
Chefarzt: Dr. med. Thorsten Kienast
Tel.:
----Fax:
----E-Mail: [email protected]
NEU: Spezialstation für Borderline Persönlichkeitsstörungen und komorbide Sucht,
Eröffnung Herbst
Universitäre Klinik für Psychosomatische
Medizin und Psychotherapie
Chefarzt: Prof. Dr. med. Dipl.-Psych. Bernd Löwe
Tel.:
----Fax:
----E-Mail: [email protected]
Die Schön Klinik Hamburg Eilbek - im Herzen von Hamburg - ist als
akademisches Lehrkrankenhaus der Universität Hamburg mit über
Betten, über .... Mitarbeiterinnen und Mitarbeitern und über ....
Patienten im Jahr eines der größten Krankenhäuser in Hamburg.
Schön Klinik Hamburg Eilbek
Dehnhaide
Hamburg
www.schoen-kliniken.de/eil
11
Die Rhein-Jura Klinik ist eine von der PKV anerkannte
private Akutklinik nach §107 (1) SGB V für Psychiatrie,
Psychosomatik und Psychotherapie.
PD Dr. med Michael Berner
Universitätsklinikum Freiburg
Ärztlicher Direktor
der Rhein-Jura Klinik
Die modern ausgestattete Rhein-Jura Klinik in Bad Säckingen liegt im Dreieck
Freiburg, Basel und Zürich. Die Gegend Südschwarzwald und Schweizer Jura gilt
als eine der schönsten Regionen Europas. Von allen Richtungen ist die Klinik
bestens erreichbar.
Die Synthese zwischen Ortslage, der sich in die Landschaft eingefügten Gebäude
und vor allen Dingen die hochqualifizierten Mediziner und Psychologen mit sehr
motivierten Mitarbeitern werden Sie rasch überzeugen, hier gut aufgehoben zu sein.
Die 115 Patientenzimmer sind komfortabel ausgestattet mit Balkon, Bad/Dusche,
TV und Telefon. Für die Internetnutzung steht eine modernst ausgestatte Mediathek
zur Verfügung.
Prof. Dr. med. Mathias Berger
Universitätsklinikum Freiburg
Wissenschaftlicher Beirat
Sowohl niedergelassene Ärzte als auch Kliniken können sofort eine
Aufnahme in die Rhein-Jura Klinik veranlassen. Aufgenommen werden
Privatversicherte, Selbstzahler und Beihilfeberechtigte.
Wir behandeln
Zentralinstitut für Seelische
Gesundheit, Mannheim
Wissenschaftlicher Beirat
Kooperationspartner
Wir bieten
Affektive Störungen
› Depressionen
› Akute Belastungsreaktion
› Burn-Out-Syndrome
Schlafstörungen
› Schlafapnoe
› Insomnie
› Restless-Leg-Syndrom
Angststörungen
› Traumafolgestörungen
› Panikstörungen
› Zwangsstörungen
Abhängigkeitsstörungen
› Substanzen
› Medikamente
› Spiel- und Internet-Sucht
Somatoforme Störungen
› Schmerzstörungen
Persönlichkeitsstörungen
Essstörungen
› Rasche stationäre Aufnahme
in Krisenfällen
› Individualisierte störungsspezifische Psychotherapie auf
wissenschaftlicher Grundlage
› Moderne Verhaltenstherapie
› Dialektisch Behaviorale Therapie
› Cognitive Behavioral Analysis
System of Psychotherapy (CBASP)
› Achtsamkeitsbasierte Therapie
› Körper-Therapie
Rhein-Jura Klinik
Schneckenhalde 13 - 79713 Bad Säckingen
Telefon: +49(0) 7761-5600-0
Telefax: +49(0) 7761-5600-105
Internet: www.rhein-jura-klinik.de
®
Format Descriptions, Topics and Programme Structure
Format Descriptions
G Plenary Sessions (PL)
Duration: 45 min
Eminent experts will present papers on the congress‘ main topics.
G Symposia (S)
Each symposium at the congress is scheduled
for 90 minutes which equals four speakers
chaired by two scientists.
G Practice Seminars (PS)
Practice Seminars help to further broaden the
participant‘s expertise in a particular field of
knowledge. The duration of each course is
either 90 or 180 minutes. The participation at
these courses is not included in the congress
registration fee.
G Oral presentations (OP)
Duration: 10 min + 5 min
The 90 minutes sessions are grouped by topics
and chaired by selected specialists. The time
slot for a single presentation in a free communication is 15 minutes including discussion time.
G Posters (P)
There will be eleven poster sessions during the
congress. The posters will be grouped into thematic Guided Poster Tours chaired by renowned
specialists. The Guided Poster Tours will give
the authors the opportunity to present their find
ings and discuss them with the audience. The
best posters will be awarded.
G Round-Table (RT)
Round-Table for specialists, affected persons
and interested people.
Topics
1. ADHD
2. Adolescence
3. Aggression
4. Animal Studies
5. Antisocial Behavior
6. Anxiety Disorder
7. Depression
8. Dissociation
9. Dialectical Behavioural Therapy
10. Eating Disorders
11. Emotion Regulation
12. Epidemiology
13. Family
14. Genetic, Environment Interaction
16. Mentalization Based Therapy
17. Neurobiology
18. Nursing Care
19. Offsprings
20. Pharmacology
21. Psychodynamically Informed Psychiatric
Care
22. Psychopathology
23. PTSD
24. Schema Therapy
25. Selfharm and Pain
26 . Social Phobia
27. Substance Use Disorders
28. Somatic Comorbidities
29. Suicidality
30. Transference Focussed Psychotherapy
Congress Language
The official language of the 1st International
Congress on Borderline Personality Disorder is
English. A selection of sessions, marked with
, will be held in German. Sessions, marked
with
, will be held in English. Simultaneous
translation will be provided for selected sessions only, marked with .
Programme Structure
The congress programme is sorted by topics (p. 20 – 24) and chronologically by days (p. 25 – 60).
For better orientation sessions within the scientific programme are differentiated by colour:
S
PS
PL
FS
Symposium
Practice Seminar
Plenary Session
Further Session
P
SP
OP
RT
Poster Session
Special Session
Oral Presentation
Round Table
The programme is sorted by G Day G Time and location G Session type
13
Thu
01 Programme Overview
Hall / Saal B 7/8
S-002 Borderline
Personality Disorder and ADHD –
Differentialdiagnosis, Comorbidity and Treatment
S-003 Impulsive
Aggression in
BPD: Genetics
and Neurobiology
Hall / Saal B 09
S-004 Deliberate self-harm
and personality
development
S-005 The
measurement of
borderline and
related characteristics
P-001, P-002, P-003, P-004, P-005
Poster Session G Foyer on Level C
OP-002 Comorbidity
PS-106 Adoles
cent Identity
Treatment: A
new approach to
identifying and
treating personality pathology in
adolescence
PS-105 Early
intervention for
borderline personality disorder
in youth
OP-005 Adoles
cents
S-007 Emotional
Dysregulation in
Borderline Per
sonality Disorder
OP-003 Single
Cases and Treatment
OP-006 Experimental Psycho
pathology
OP-008 Psychodynamic
Cases
OP-009 Psychotherapy Trials
Foyer on Level B: Get Together
14
Hall / Saal A 01
S-008 Facets
of Impulsivity
in BPD
Technical Exhibition: 09.00 – 17.00 h
9 S-001 What’s the
difference that
makes the differ ence? …
10 11 PL-001 The epidemiology of border line personality
disorder: …
PL-002 Dimensio
12 nal Assessments
for Borderline Per sonality …
13 SP-001
Opening
14 Ceremony
15 OP-001 Diagnos
tics
16 OP-004 Etiology
17 18 OP-007 Symptom
Assessment
19 20 Hall / Saal B 5 / 6
Registration Counter: 08.00 – 19.00 h
Hall / Saal C 01
Programme Overview
Hall / Saal A 03
Hall / Saal A 04
Hall / Saal A 05
Hall / Saal A 06
S-006 Comorbidity
between BPD
and APD:
Diagnostic and
clinical issues
PS-101 How to
be mindful to
teach mindfulness?
PS-102 DBTACES – Ein dialektisch behavioraler Ansatz zur
Verbesserung
der Lebensqualität von Patien
ten mit BPS
PS-104 Skills
für Therapeuten:
Wie wir uns in
Teamarbeit und
Supervision gegenseitig effektiv unterstützen
können
Room /
Raum B 03
FS-001
Opening Press
Conference
P-001, P-002, P-003, P-004, P-005
PS-108 Treatment of comorbid ADHD in
patients with
BPD
PS-109 Dialectical Behavior
Therapy for
Posttraumatic
Stress Disorder
(DBT-PTSD)
after childhood
sexual abuse: A
new treatment
PS-110 Behand- PS-111 DBTlung komorEssstörung
bider AD(H)S
bei Patienten
mit BorderlinePersönlichkeitsstörung
PS-112 Schema
Mindfulnessbased cognitive therapy
(MBCT): How
to incorporate
mindfulness in
schematherapy?
PS-113 How to
manage attachment trauma
in borderline
patients by
MentalizationBased Treatment: …
PS-114 Clinical use of
attachment
interviews in
the diagnostics
of Borderline
Personality
Disorders
PS-115 A frame- PS-116 Einwork for the
führung in das
treatment of the Skillstraining
difficult to treat
person with
severe personality disorders
and …
01
Room /
Raum C 03
PS-103 Arbeit
mit der neuen
Skills-CD – Ver
änderungen im
Skillstraining
PS-107 Workshop Schema
Therapy for
Borderline
Personality
Disorder
Thu
Foyer on Level B: Get Together
15
9
10
11
12
13
14
15
16
17
18
19
20
Hall / Saal B 5 / 6
Hall / Saal B 7/8
Hall / Saal B 09
Hall / Saal A 01
S-009 Treatment
of Posttraumatic
Stress Disorder
in patients suffer
ing from Borderline Personality
Disorder
S-010 Dissoziation –Neurobiolo
gische Mechanis
men und therapeutische
Implikationen
S-011 Trans
ference-Focused
psychotherapy:
State of the art
S-012 Biological
studies and
considerations in
borderline per
sonality disorder
S-013 Adoles
cence and borderline personality: Experience
from a European
french-speaking
research network
PL-003 Epigenetics in the control
of behavior
PL-004 Neurobiological Findings in
Borderline Personality Disorders …
P-006, P-007, P-008, P-009, P-010, P-011
S-014 Mentaliza
tion-based treatment for borderline personality
disorder: …
S-015 Affective
instability in
borderline per
sonality disorder
S-016 Memory
alterations in
patients with borderline personal
ity disorder: …
S-017 Social
cognitions and
emotions in the
interpersonal
context
S-018 From
parenthood to
suicidality, diffe
rent aspects of
care possibilities
in borderline personality disorder
OP-010 Treat
ment Develop
ment and
Training
SP-002 DSM-V:
Do we have to
change the
course of DSM-V
PD work group
proposal? Round
Table Debate
PS-122 Transference-Focused
Psychotherapy
for Borderline
Patients
PS-128 DBT
Mindfulness Radical Acceptance
and Willingness
PS-129 BPD
Psychoeducation:
Collaborating for
Change Family
Members as
Clinical Allies
OP-011 Psychopathology
OP-012 Neuro
biology
S-024 Findings
from a Canadian
randomized trial
comparing dialectical behaviour
therapy to general
psychiatric management: …
S-025 Outpatient
DBT-treatment
systems in
Europe
OP-013 PTSD
S-026 Dialectical
behavior therapy
for substance
abuse in individuals with borderline personality
disorder: …
OP-014 Pharmacology
from 20.30 h: Congress Dinner at Restaurant Nolle
16
9 10 11 12 13 14 15 16 17 18 19 20 Hall / Saal C 01
Technical Exhibtion: 09.00 – 17.00 h
Fri
Programme Overview
Hall / Saal A 03
PS-117 Umgang
mit Grenzen und
Kontingenzen in
der ambulanten
und stationären
DBT
Hall / Saal A 04
Hall / Saal A 05
PS-118 Group
Schema Therapy
for Borderline Personality Disorder:
Model, Therapist
Style, Core Tech
niques and Empirical Validation
PS-119 DBT in der
Tagesklinik – Zwei
Modelle
Hall / Saal A 06
Room/Raum B 03
9
10
11
12
13
S-023 Dialectical
Behavior Therapy
14
(DBT) training in
Europe: Sharing
the experience
15
PS-127 DBT-Eating Disorders
16
17
18
PS-132 Körper
therapie in der DBT
19
20
PS-120 Wie vermit- PS-121 Schematele ich Achtsamtherapie bei
keit?
Borderline
Persönlichkeits
störung
P-006, P-007, P-008, P-009, P-010, P-011
S-019 Neurobiological Aspects of
Emotion, Motivation and Impulsive
Behavior from
Neuroimaging
Studies
S-020 Neuroimag
ing in adolescent
S-021 Basic mecha- S-022 Emotion
nisms of aversive
regulation in BPD:
learning in BPD
Assessment, psychopathology and
treatment
PS-123 Einführung
in die Dialektisch
Behaviorale The
rapie bei Patienten
mit BorderlinePersönlich
keitsstörung und
komorbidem Substanzmissbrauch
oder -abhängigkeit
(DBT-S)
PS-124 DBT-A in
der stationären
Kinder- und
Jugendpsychiatrie
PS-125 Grundlagen,
Behandlungsmethoden und
-instrumente der
Dialektisch-Behavioralen Therapie
(DBT) im Rahmen
eines stationären
Therapiekonzeptes
PS-126 DialektischBehaviorale Therapie der Posttraumatischen Belastungsstörung nach
sexualisierter
Gewalt in der Kindheit – eine neue
Behandlung
S-027 Integrating
emotional regula
tion and psychobiological findings
in BPD
PS-132 A Dialectical Behavior Therapy with Parents
and Partners to
Augment Individual
Outcomes
PS-130 The use
of imagery in a
schema group
therapy
PS-131 DBT in
komplementären
Arbeitsfeldern der
Sozialpsychiatrie –
Chancen, Grenzen
und Konsequenzen
in Theorie und
Praxis
Fri
02
from 20.30 h: Congress Dinner at Restaurant Nolle
17
9 10 11 12 Hall / Saal B 5 / 6
Hall / Saal B 7 / 8
Hall / Saal B 09
Hall / Saal A 01
S-028 New developments in
schema therapy
for Borderline
Personality Disorder
S-029 New approaches to identity disturbance:
Self-esteem and
self-concept in
borderline personality disorder …
RT-001 Round
Table: Betroffenen-Diskussionsforum: Ich sehe
was, was Du nicht
siehst …
PS-138 Clinical
subgroups of patients with borderline personality
disorder: Description, assessment
and specific intervention strategies
S-030 Pharmaco
therapy in Borderline Personality Disorder:
Metaanalyses
and latest developments
PL-005 Mentaliza
tion Based Therapy – State of the
Art
PL-006 Dialectical
Behavior Therapy
(DBT): Where Are
We Now?
Technical Exhibtion: 09.00 – 12.30 h
9 10 11 12 13 Hall / Saal C 01
Sat
SP-003 Closing &
Award Ceremony
Hall / Saal A 03
Hall / Saal A 04
PS-133 Psycho
education for
patients with
Borderline
Personality Disorder (BPD)
PS-134 Healing insecure
attachment
representations
and managing
emotions
18
Hall / Saal A 05
Hall / Saal A 06
PS-135 ModiPS-136 Einfüh
fied dialectical rung in Stepps
behavior therapy for individuals with intellectual disabilities
Room /
Raum B 03
Room /
Raum B 95
PS-137 Struktur
und Inhalte für
die Pflege der
Dialektischbehavioralen
Therapie der
Essstörung
S-031 Inter
action of
disturbed pain
processing and
self-injurious
behavior
STEPPS – Erfolgreiches Emotionstraining für Menschen mit
Borderline-Persönlichkeitsstörungen
STEPPS (Systems
Training for Emotional Predictability and
Problem Solving) ist ein
strukturiertes Trainingsprogramm für Menschen mit BorderlinePersönlichkeitsstörung. Es ist aber auch
ein wirksames Angebot für alle, die an
einer Störung der Emotionsregulation
leiden. Ziel ist, betroffene Menschen zu
befähigen, mit professionellen Helfern,
mit Angehörigen und Freunden klarer
über ihre Erkrankung und die notwendigen Schritte zur Bewältigung zu
kommunizieren. Im Rahmen einer festen
Gruppe mit Seminarcharakter erlernen
die Teilnehmerinnen und Teilnehmer
Fertigkeiten für einen besseren Umgang
mit ihren Emotionen und zur Steuerung
ihres Verhaltens.
 

STEPPS-Trainerfortbildung
STEPPS ist eine gute Ergänzung zu bestehenden therapeutischen Angeboten wie
z. B. DBT. Man braucht keine psychotherapeutische Ausbildung, um mit diesem
Programm zu arbeiten.
Um STEPPS effektiv einzusetzen, bietet
der Dachverband STEPPS Fortbildungen
an. Informieren Sie sich auf dem Kongress am Stand des Psychiatrie-Verlags
oder nehmen Sie an dem Praxis-Seminar
teil:
Samstag, 3. Juli 2010, 09.00 - 10.30 Uhr
Einführung in Stepps mit Dr. Ursula
Herrmann und Dr. Ewald Rahn
 
 
Das Trainingsprogramm bei Borderline / Trainerhandbuch
Das Trainerhandbuch enthält die Moderatorenleitlinien für 20 Wochensitzungen sowie die ausgearbeiteten Unterrichtsstunden plus Downloads vieler
Arbeitsmaterialien. Für Gruppen-Teilnehmende
gibt es die Unterlagen als Loseblattsammlung im
Ordner.
Blum, Bartels, St. John, Pfohl
Solving) ist ein strukturiertes Trainingsprogramm für Menschen mit Borderline-Persönlichkeitsstörung. Es ist aber auch ein wirksames Angebot für alle,
die an einer Störung der Emotionsregulation leiden. Ziel ist, betroffene
Menschen zu befähigen, mit ihren Therapeuten, mit Angehörigen und
Freunden klarer über ihre Erkrankung und die notwendigen Schritte zur
Bewältigung zu kommunizieren. Darüber hinaus lernen die Teilnehmenden
spezifische Fertigkeiten für einen angemesseneren Umgang mit ihren
Emotionen und zur Steuerung ihres Verhaltens.
Die Alltagsnähe des Emotionstrainings ist das ganz große Plus dieses
Ansatzes. Neben einem Problemlösetraining werden auch Fertigkeiten wie
das Essverhalten und die Freizeitgestaltung unter die Lupe genommen
und neue Verhaltensweisen eingeübt.
Das Manual bezieht Angehörige und Freunde ein. Gemeinsam bilden sie das
»Helfer-Team«, das den Betroffenen bei den neu erworbenen Fertigkeiten
stützt und fördert.
STEPPS ist eine gute Ergänzung zu bestehenden therapeutischen Angeboten
wie z. B. DBT. Man braucht keine therapeutische Ausbildung, um mit diesem
Programm zu arbeiten.
In den USA und in den Niederlanden wird STEPPS seit Jahren mit sehr
guten Ergebnissen eingesetzt. Ewald Rahn hat das Programm übersetzt und
gemeinsam mit Ursula Herrmann bearbeitet und erfolgreich in Warstein
evaluiert.
STEPPS
STEPPS (Systems Training for Emotional Predictability and Problem
Die Materialien
STEPPS
Nancee S. Blum, Norman E. Bartels, Don St. John, Bruce M. Pfohl
Das Trainingsprogramm
bei Borderline
Emotionale Krisen bewältigen,
Probleme lösen, Alltag gestalten,
Beziehungen aufbauen
Trainer-Handbuch
Übersetzt und bearbeitet von Ewald Rahn und Ursula Herrmann
ISBN 978-3-88414-449-7
N. Blum, N. F. Bartels, D. St. John, B. Pfohl
STEPPS - Das Trainingsprogramm bei Borderline:
Emotionale Krisen bewältigen, Probleme lösen, Alltag
gestalten, Beziehungen aufbauen. Trainerhandbuch
ISBN 978-3-88414-449-7, 304 S., geb., 125.00 Euro
Übersetzt und bearbeitet von Ewald Rahn
und Ursula Herrmann
Bei Teilnahme an den Fortbildungen sind die Materialien
in der Gebühr enthalten.
www.psychiatrie-verlag.de
STEPPS
Das Trainingsprogramm
www.dachverband-stepps.de
Das Trainingsprogramm/Arbeitsbuch
STEPPS
Arbeitsbuch
Emotionale Krisen bewältigen
Probleme lösen
Alltag gestalten
Beziehungen aufbauen
STEPPS - Arbeitsbuch
im DIN A4-Ordner,
280 Seiten, 39.95 Euro
978-3-88414-499-2
www.psychiatrie-verlag.de
19
Scientific Programme by Topic
1. ADHD
5. Antisocial Behavior
page 26
S-002 Borderline Personality Disorder and ADHD – Dif
ferentialdiagnosis, Comorbidity and Treatment
page 27
S-006 Co-Morbidity between BPD and APD:
Diagnostic and clinical issues
PS-108 page 34
Treatment of comorbid ADHD in patients with
BPD
6. anxiety disorder
PS-110 page 34
Behandlung komorbider AD(H)S bei Patienten
mit Borderline-Persönlichkeitsstörung
P-004 Anxiety Disorder
page 31
8. Dissociation
OP-002 Comorbidity
page 35
page 41
S-010 Dissoziation – Neurobiologische Mechanismen
und therapeutische Implikationen
2. Adolescence
page 42
S-013 Adolescence and borderline personality: Experience from a European french-speaking research network
S-004 page 27
Deliberate self-harm and personality development
S-020 page 50
Neuroimaging in adolescent borderline personality disorder
PS-101 page 28
How to be mindful to teach mindfulness?
page 28
PS-103 Arbeit mit der neuen Skills-CD – Veränderungen im Skillstraining
PS-104 page 28
Skills für Therapeuten: Wie wir uns in Team
arbeit und Supervision gegenseitig effektiv un
terstützen können
PS-120 Wie vermittele ich Achtsamkeit?
page 43
PS-105 page 33
Early intervention for borderline personality
disorder in youth
page 53
OP-010 Treatment Development and Training
OP-005 Adolescents
page 36
9. Dialectical Behavioural Therapy
P-010 Adolescence
page 46
page 26
S-001
What’s the difference that makes the difference?
Commonalities and differences across efficacious treatments for BPD
3. Aggression
page 26
S-003 Impulsive Aggression in BPD: Genetics and
Neurobiology
S-008 Facets of Impulsivity in BPD
20
= Deutsch = English
page 38
S-023 page 51
Dialectical Behavior Therapy (DBT) training in
Europe: Sharing the experience
S-024 page 54
Findings from a Canadian randomized trial com
paring dialectical behaviour therapy to general
psychiatric management: Predictors of dropout, risk factors for suicide and patterns of
health care utilities
S-025 page 55
Outpatient DBT-treatment systems in Europe
page 55
S-026 Dialectical behavior therapy for substance abuse
in individuals with borderline personality dis
order: Results from a multi-centre randomized
controlled trial
PS-102 page 28
DBT-ACES – Ein dialektisch behavioraler Ansatz
zur Verbesserung der Lebensqualität von Patienten mit BPS
PS-116 Einführung in das Skillstraining
page 38
page 43
PS-117 Umgang mit Grenzen und Kontingenzen in der
ambulanten und stationären DBT
PS-119 page 43
DBT in der Tagesklinik – Zwei Modelle
page 52
PS-123 Einführung in die Dialektisch Behaviorale The
rapie bei Patienten mit Borderline-Persönlich
keitsstörung und komorbidem Substanzmissbrauch oder -abhängigkeit (DBT-S)
PS-124 page 52
DBT-A in der stationären Kinder- und Jugend
psychiatrie
PS-131 page 56
DBT in komplementären Arbeitsfeldern der
Sozialpsychiatrie – Chancen, Grenzen und Konsequenzen in Theorie und Praxis
PS-132 Körpertherapie in der DBT
page 56
page 56
PS-132 A Dialectical Behavior Therapy with Parents and
Partners to Augment Individual Outcomes
PS-133 page 59
Psychoeducation for patients with Borderline
Personality Disorder (BPD)
PS-135 page 59
Modified dialectical behavior therapy for individuals with intellectual disabilities
PS-136 Einführung in Stepps
page 59
page 59
PS-137 Struktur und Inhalte für die Pflege der Dialek
tisch-behavioralen Therapie der Essstörung
P-006 Dialectical Behavioural Therapy
page 43
10. Eating Disorders
PS-111 DBT-Essstörung
page 34
PS-127 DBT-Eating Disorders
page 52
11. Emotion Regulation
PS-125 page 52
Grundlagen, Behandlungsmethoden und -instru
mente der Dialektisch-Behavioralen Therapie
(DBT) im Rahmen eines stationären Therapiekonzeptes
PS-128 page 52
DBT Mindfulness Radical Acceptance and Wil
lingness
page 37
S-007 Emotional Dysregulation in Borderline Personality Disorder
S-015 page 49
Affective instability in borderline personality
disorder
= Deutsch = English
21
S-022 page 51
Emotion regulation in BPD: Assessment, psychopathology and treatment
S-027 page 55
Integrating emotional regulation and psychobiological findings in BPD
14. genetic, environment
interaction
P-001 Genetic, Environment Interaction
page 29
15. Healthcare and Economics
PS-112 page 38
Schema Mindfulness-based cognitive therapy
(MBCT): How to incorporate mindfulness in
schematherapy?
PS-114 page 38
Clinical use of attachment interviews in the
diagnostics of Borderline Personality Disorders
PS-115 page 38
A framework for the treatment of the difficult to
treat person with severe personality disorders
and substance use disorder
P-011 Healthcare and Economics
page 47
16. Mentalization Based Therapy
page 48
S-014
Mentalization-based treatment for borderline
personality disorder: A summary of the evidence, new evidence and recent developments in
different dosages and treatment population
PS-134 page 59
Healing insecure attachment representations
and managing emotions
PS-113 page 38
How to manage attachment trauma in borderline patients by Mentalization-Based Treatment:
Therapeutical relationship and setting
P-005 Emotion Regulation
17. Neurobiology
page 32
page 41
S-011 Transference-Focused psychotherapy: State of
the art
12. Epidemiology
OP-004
Etiology
page 36
OP-009 Psychotherapy Trials
page 40
S-012 page 42
Biological studies and considerations in borderline personality disorder
S-021 page 51
Basic mechanisms of aversive learning in BPD
13. Family
page 52
PS-129 BPD Psychoeducation: Collaborating for Change
Family Members as Clinical Allies
page 49
S-016 Memory alterations in patients with borderline
personality disorder: Experimental research and
clinical implications
S-019 page 50
Neurobiological Aspects of Emotion, Motivation
and Impulsive Behavior from Neuroimaging
Studies
OP-008 Psychodynamic Cases
22
= Deutsch = English
page 39
OP-012 Neurobiology
page 54
OP-006 Experimental Psychopathology
page 37
P-003 Neurobiology
page 30
OP-007 Symptom Assessment
OP-011
Psychopathology
page 38
page 58
S-030 Pharmacotherapy in Borderline Personality Disorder: Metaanalyses and latest developments
P-002 Psychopathology
page 29
OP-014 Pharmacology
23. PTSD
20. Pharmacology
page 57
page 53
page 41
S-009
Treatment of Posttraumatic Stress Disorder in
patients suffering from Borderline Personality
Disorder
21. Psychodynamically
Informed Psychiatric Care
OP-003 Single Cases and Treatment
page 35
OP-001 Diagnostics
page 34
PS-109 page 34
Dialectical Behavior Therapy for Posttraumatic
Stress Disorder (DBT-PTSD) after childhood
sexual abuse: A new treatment
page 45
P-008 Psychodynamically Informed Psychiatric Care
PS-121 page 43
Schematherapie bei Borderline Persönlichkeits
störung
22. Psychopathology
page 27
S-005 The measurement of borderline and related
characteristics
S-017 page 49
Social cognitions and emotions in the interpersonal context
PS-126 page 52
Dialektisch-Behaviorale Therapie der Posttraumatischen Belastungsstörung nach sexualisier
ter Gewalt in der Kindheit – eine neue Behandlung.
OP-013
PTSD
page 56
24. Schema Therapy
S-029 page 58
New approaches to identity disturbance: Selfesteem and self-concept in borderline personality disorder and their relevance to psychotherapy
PS-138 page 60
Clinical subgroups of patients with borderline
personality disorder: Description, assessment
and specific intervention strategies
page 58
S-028
New developments in schema therapy for Borderline Personality Disorder
PS-107 page 33
Workshop Schema Therapy for Borderline Personality Disorder
= Deutsch = English
23
PS-118 page 43
Group Schema Therapy for Borderline Personality Disorder: Model, Therapist Style, Core Tech
niques and Empirical Validation
P-007
Anxiety Disorder
PS-130 page 56
The use of imagery in a schema group therapy
29. Suicidality
25. Selfharm and Pain
page 59
S-031 Interaction of disturbed pain processing and
self-injurious behavior
page 44
page 50
S-018 From parenthood to suicidality, different aspects of care possibilities in borderline personality disorder
page 33
PS-106 Adolescent Identity Treatment: A new approach
to identifying and treating personality pathology
in adolescence
PS-122 page 52
Transference-Focused Psychotherapy for Bor
derline Patients
P-009 Behandlungsentwicklung
Please visit the Technical
Exhibition on Level B
24
= Deutsch = English
Thu, 01 July 2010 Fri, 02 July 2010 Sat, 03 July 2010 page 46
09.00 – 17.00 h
09.00 – 17.00 h
09.00 – 12.30 h
Plenary Sessions
Thursday, 1 July
PL-001
Plenary Session
11.00 – 11.45 h // Hall C 01
The epidemiology of borderline personality
disorder: the state of the art
GPeter Tyrer
Imperial University, Community Psychiatry
(London, United Kingdom)
Moderation: Martin Bohus (Mannheim,
Germany)
Plenary Session
PL-002
11.45 – 12.30 h // Hall C 01
Dimensional Assessments for Borderline Per
sonality Disorder in DSM-5
GAndrew E. Skodol
University of Arizona, Sunbelt Collaborative
(Tucson, USA)
Moderation: John Oldham (Houston, USA)
Friday, 2 July
PL-003
Plenary Session
11.00 – 11.45 h // Hall C 01
Epigenetics in the control of behavior
GMoshe Szyf
McGill University, Pharmacology and
Therapeutics (Montreal, Canada)
Moderation: Ulrich Schweiger (Lübeck,
Germany)
Plenary Session
PL-004
11.45 – 12.30 h // Hall C 01
Neurobiological Findings in Borderline Personality Disorders – State of the Art
GSabine C. Herpertz
Universität Heidelberg, Klinik für Allgemeine
Psychiatrie (Heidelberg, Germany)
Moderation: Christina Schmahl (Mannheim,
Germany)
Saturday, 3 July
PL-005
Plenary Session
11.00 – 11.45 h // Hall C 01
Mentalization Based Therapy – State of the
Art
GPeter Fonagy
UCL Psychoanalysis Unit, Research Dept. of
Clinical, Educational and Health Psychology
(London, United Kingdom)
Moderation: Sabine C. Herpertz (Heidelberg,
Germany)
Plenary Session
PL-006
11.45 – 12.30 h // Hall C 01
Dialectical Behavior Therapy (DBT): Where
Are We Now?
GMarsha Linehan
University of Washington, Dept. of Psychology
(Washington, USA)
Moderation: Thorsten Kienast (Hamburg,
Germany)
= Deutsch = English
25
Thu
Symposium
S-001
09.00 – 10.30 h // Hall C 01
Topic 9: Dialectical Behavioural Therapy
What’s the difference that makes the difference? Commonalities and differences across
efficacious treatments for BPD
Chair: L. Dimeff (Seattle, USA)
Co-Chair: V. Porr (New York, USA)
001
Mentalization based treatment (MBT) and its
relationship to other psychotherapies for borderline personality disorder
A. Bateman, St. Ann‘s Hospital, VISPD (London,
United Kingdom)
002
Transference Focused Psychotherapy (TFP)
F. Yeomans, (USA)
003
Dialectical Behavior Therapy
L. Dimeff, BTECH Research, Inc., Research Inst.
(Seattle, USA)
004
TARA DBT-MBT Family Training
V. Porr, TARA, Research Inst. (New York, NY,
USA)
Discussant: G. Feinberg (USA)
J. Oldham, The Menninger Clinic, Psychiatry and
Behavioral (Houston, USA)
Symposium
S-002
09.00 – 10.30 h // Hall B 5/6
Topic 1: ADHD
Borderline Personality Disorder and ADHDDifferentialdiagnosis, Comorbidity and Treatment
Chair: A. Philipsen (Freiburg, Germany)
Co-Chair: S. Matthies (Freiburg, Germany)
001
Borderline Personality Disorder and childhood ADHD: Putting a controversial issue in a
developmental perspective
A. Fossati, Vita-Salute San Raffaele Univ. (Milan,
Italy)
S. Borroni, C. Maffei
26
= Deutsch = English
002
ADHD as an aggravating factor in adults with
BPD
A. Philipsen, Universitätsklinikum Freiburg, Psychiatrie und Psychotherapie (Freiburg, Germany)
003
Emotion dysregulation and impulsivity in BPD
and ADHD: comparative fMRI studies
O. Tüscher, Universitätsklinikum Freiburg, Psychiatrie & Psychotherapie (Freiburg, Germany)
K. Bader, G. Jacob, K. Lieb
004
ADHD in female offenders: prevalence, psychiatric co-morbidity and psychosocial implications
W. Retz, Universitätsklinikum Homburg
(Homburg, Germany)
S-003
Symposium
09.00 – 10.30 h // Hall B 7/8
Topic 3: Aggression
Impulsive Aggression in BPD: Genetics and
Neurobiology
Chair: L. Siever (New York, USA)
Co-Chair: C. Schmahl (Mannheim, Germany)
001
New genetic findings in aggression and BPD
J. Kennedy, (Toronto, Ont., Canada)
002
Social and emotional processing in personal
ity disorder and aggression
E. Coccaro, (Chicago, USA)
003
Glutamate levels in the anterior cingulate cortex correlate with self-reported impulsivity in
patients with borderline personality disorder
and healthy controls
C. Schmahl, ZI für Seelische Gesundheit, Psychosomatische Medizin (Mannheim, Germany)
M. Hoerst, G. Ende, M. Bohus
004
Circuitry and Genetics of Aggression in BPD
L. Siever, Mount Sinai School of Medicine, Dept.
of Psychiatry (New York, USA)
Thu
Scientific Programme by Day 01
S-004
Symposium
09.00 – 10.30 h // Hall B 09
Topic 2: Adolescence
Deliberate self-harm and personality development
Chair: R. Brunner (Heidelberg, Germany)
Co-Chair: F. Resch (Heidelberg, Germany)
001
Psychopathology and psychopathy in adolescent male and female detainees
K. Sevecke, Universitätsklinik Köln, Kinder- und
Jugendpsychiatrie (Cologne, Germany)
M. Krischer
002
Self-harming and suicidal behaviour in adolescents – is there a gender-specific predisposition?
M. Kaess, Med. Universität Heidelberg, Kinderund Jugendpsychiatrie (Heidelberg, Germany)
P. Parzer, J. Haffner, J. Roos, M. Klett, R. Brunner,
F. Resch
003
Psychopharmacotherapy improves psychosocial functioning in adolescents with borderline personality disorder
L. Wöckel, Universitätsklinik Aachen, Kinderund Jugendpsychiatrie (Aachen, Germany)
K. Goth, F. D. Zepf, N. Matic, B. HerpertzDahlmann, F. Poustka
004
Pain Perception in female adolescents diagnosed with Borderline Personality Disorder
(BPD): Results from a study using quantitative
sensory testing
C. von Kalckreuth, Med. Universität Heidelberg,
Kinder- und Jugendpsychiatrie (Heidelberg,
Germany)
Symposium
S-005
09.00 – 10.30 h // Hall A 01
Topic 22: Psychopathology
The measurement of borderline and related
characteristics
Chair: R. Bell (Melbourne, Australia)
Co-Chair: A. Chanen (Melbourne, Australia)
001
The latent structure of borderline criteria:
Categorical, dimensional, or both?
R. Bell, University of Melbourne, Psychological
Sciences (Melbourne, Australia)
002
Confirmatory factor and item response theory
analyses of the borderline personality questionnaire
J. Boldero, University of Melbourne, Orygen
Youth Health (Melbourne, Australia)
003
The structure of the Difficulties in Emotion
Regulation Scale and relationships with borderline personality disorder features
C. Hulbert, University of Melbourne, Orygen
Youth Health (Melbourne, Australia)
004
The relationship of borderline personality disorder to other personality disorders
R. Mulder, University of Otago, Orygen Youth
Health (Christchurch, New Zealand)
Symposium
S-006
09.00 – 10.30 h // Hall A 03
Topic 5: Antisocial Behavior
Co-Morbidity between BPD and APD: Diagnostic and clinical issues
Chair: A. Ivanoff (New York, USA)
Co-Chair: L. van den Bosch (Deventer, The
Netherlands)
001
Co-morbidity between Borderline and Antisocial Personality Disorders: Other Axis II diagnoses and disturbances
M. P. Heyes, Columbia University, School of
Social Work (New York, USA)
= Deutsch = English
27
Thu
002
Antisocial and Borderline Characteristics in
Stalking Offenders: Examining a Clinical
Sample
A. Ivanoff, Columbia University, School of Social
Work (New York, USA)
003
DBT for co-occurring borderline personality
disorder and antisocial personality disorder in
a maximum security women‘s correctional facility
S. Manning, Behavioral Tech., LLC (Seattle, USA)
004
Dialectical Behaviour Therapy, Forensic patients and forensic staff: Is changing the attitude effective?
L. van den Bosch, Dialexis, Dept. of Psychology
(Deventer, The Netherlands)
Practice Seminar
PS-101
09.00 – 10.30 h // Hall A 04
Topic 8: Dissociation
How to be mindful to teach mindfulness?
K. Schehr (Freiburg, Germany)
E. Max (Freiburg, Germany)
Practice Seminar
PS-102
09.00 – 10.30 h // Hall A 05
DBT-ACES – Ein dialektisch behavioraler
Ansatz zur Verbesserung der Lebensqualität
von Patienten mit BPS
K. Höschel (Münster, Germany)
Practice Seminar
PS-103
09.00 – 10.30 h // Room B 03
Arbeit mit der neuen Skills-CD – Veränderungen im Skillstraining
T. Grathwol (Koenigsfeld, Germany)
C. Fuhrhans (Littenheid, Switzerland)
28
= Deutsch = English
PS-104
Practice Seminar
09.00 – 10.30 h // Hall A 06
Skills für Therapeuten: Wie wir uns in Team
arbeit und Supervision gegenseitig effektiv
unterstützen können
F. Mayer-Bruns (Freiburg, Germany)
PL-001
Plenary Session
11.00 – 11.45 h // Hall C 01
The epidemiology of borderline personality
disorder: the state of the art
Peter Tyrer, Imperial University, Community
Psychiatry (London, United Kingdom)
Moderation: Martin Bohus (Mannheim,
Germany)
PL-002
Plenary Session
11.45 – 12.30 h // Hall C 01
Dimensional Assessments for Borderline Per
sonality Disorder in DSM-5
Andrew E. Skodol, University of Arizona,
Sunbelt Collaborative (Tucson, USA)
Moderation: John Oldham (Houston, USA)
FS-001
Further Session
12.00 – 13.00 h // Room C 03
Eröffnungspressekonferenz / Opening Press Conference
Moderation: T. Nesseler (Berlin, Germany)
M. Bohus (Mannheim, Germany)
F. Schneider (Aachen, Germany)
T. Rinne (Utrecht, The Netherlands)
A. Link (Nürnberg, Germany)
T. Kienast (Hamburg, Germany)
Thu
P-001
Poster Session
12.30 – 13.30 h // Foyer C 02
Topic 14: Genetic, Environment Interaction
Genetic, Environment Interaction
Chair: B. Schott (Berlin, Germany)
001
Borderline Personality Disorder, genetics or
environment? Antededents of childhood sexual abuse
C. García Blanco, Lundbeck Espana, Dept. of
Psychiatry (Barcelona, Spain)
S. C. Olga, F. R. Martinez Luna, M. P. Lapastora
de Mingo, A. Pose Cabarcos, F. García Sánchez,
C. Rodriguez Gomez-Carreño
002
Influence of Gender, Age and Severity on Axis
II Comorbidity in Patients with Borderline
J. Barrachina Coll, Centre Psicoterapia Barcelona, Hospital de Dia CPB (Barcelona, Spain)
J. C. Pascual, M. Ferrer Vinardell, J. Soler,
Ó. Andión-Pérez, M. J. Rufat, T. Tiana, A. Martín
Blanco, M. Casas Brugué, V. Pérez
003
Personality disorders in a sample of patients
undertaking sex reassignment surgery
A. Prunas, Università di Milano-Bicocca, Dept. of
Psychology (Milan, Italy)
D. Hartmann
004
Early Trauma and Perinatal Adversity in Borderline Personality Disorder
C. E. Schwarze, Universitätsmedizin Mainz, Psychiatrie und Psychotherapie (Mainz, Germany)
B. Pallasch, G. Hoppe, M. Kurz, A. Mobascher,
D. H. Hellhammer, K. Lieb
005
Child evacuations during World War II and
hospitalization for any and for borderline personality disorders in adulthood: A longitudinal study
M. Lahti, University of Helsinki, Institute of
Behavioural Sc. (Helsinki, Finland)
K. Räikkönen, A.-K. Pesonen, K. Wahlbeck,
K. Heinonen, E. Kajantie, C. Osmond,
D. P. J. Barker, J. G. Eriksson
006
The epidemiology of personality disorders
among Finnish prisoners
M. Joukamaa, University of Tampere, School of
Public Health (Tampere, Finland)
J. Aarnio, V. von Gruenewaldt, S. Hakamäki,
P. Viitanen, T. Wuolijoki, A. Mattila, T. Lintonen,
H. Vartiainen
007
An empirical investigation of the specific relations between subdimensions of the DSM-IV
borderline personality disorder and facets of
the Five-Factor Model of personality
L. Bastiaansen, Vrije Universiteit Brussel, Clinical & Lifespan Psychology (Brussels, Belgium)
J. Schoofs, G. Rossi, M. De Weerdt
008
An assessment of psychiatric comorbidities in
main diagnosis Borderline Personality Disorder (BPD) in naturalistically evaluated inpatients versus screened outpatients
M. Muscionico, Hôpitaux Universitaires Genève,
Belle-Idée (Chêne-Bourg, Switzerland)
P. Prada, K. Dieben, V. Kaby, R. Nicastro, J.-J.
Kunckler, B. Blanchon, C. Pepin, G. Bouillault,
P. Huguelet, N. Perroud
Poster Session
P-002
12.30 – 13.30 h // Foyer C 02
Psychopathology
Chair: J. Mauchnik (Mannheim, Germany)
001
A naturalistic study of changes in patterns of
treatment for Borderline Personality Disorder
in clinical practice: from APA to NICE guidelines
A. Martín Blanco, Hospital de Sant Pau, Dept. of
J. C. Pascual, J. Soler, T. Tiana, F. Viñas, V. Perez
Sola
002
Differential diagnosis or comorbiditiy? Bipolar II Disorder versus Borderline Personality
Disorder
O. Sobrino Cabra, Lundbeck Espana, Dept. of
C. García Blanco, A. De Cós Milás, F. García
Sánchez, R. Medina Barrios, L. Ruíz de la
Hermosa
= Deutsch = English
29
Thu
003
Psychopathological types of depressive conditions within the dynamics of borderline personality disorder (BPD) in adolescence
E. Krylova, Mental Health Research Center, Clini
cal Department of Endogen (Moscow, Russia)
A. Beburishvili
009
Relationships between personality, tendencies toward borderline personality and perceived quality of life in a non-clinical sample
G. Zecca, University of Lausanne, Institute of
Psychology (Lausanne, Switzerland)
J. Rossier
004
Treatment of patients with borderline personality disorder (BPD) and posttraumatic stress
disorder (PTSD) via narrative exposure therapy (NET) – a pilot study
J. Schmitt-Eliassen, Zentrum für Integrative
Psychiatrie ZIP gGmbH (Kiel, Germany)
P. Astrid, R. Maggie, K.-V. Silja, B.-J. Christina,
B. Kirstin, A. Josef B.
010
Confirmatory Factor Analysis of DSM-IV Criteria for Borderline Personality Disorder:
Testing Clinical Validity (preliminary results)
Ó. Andión-Pérez, Hospital Vall d’Hebron, Servei
de Psiquiatría (Barcelona, Spain)
M. Ferrer Vinardell, B. Gancedo Villegas,
N. Calvo Piñero, C. Barral Picado, A. Di Genova,
R. Torrubia Beltri, M. Casas Brugué
005
Predictive function of evasive personality disorder traits on the outcome of treatment of
borderline personality disorder, preliminary
study
R. Boeye, Aarhus University Hospital, Clinic for
Personality Disorder (Risskov, Denmark)
C. Freund, H. Jordet, D. Andersen,
C. R. Joergensen, M. Kjoelbye
011
Comparing ICD-10 criteria of borderline personality disorder in inpatients of psychosomatic medicine treatment with and without
posttraumatic stress disorder
R. Noack, Universitätsklinik Dresden, Psychoso
matische Medizin (Dresden, Germany)
J. Mrose, A. Keller, P. Joraschky
006
Borderline criteria are scattered through personality axes
L. Ramos Ferraz, Fundació Clinic Barcelona
(Barcelona, Spain)
F. Gutiérrez, M. Gárriz, J. M. Peri
P-003
007
Prevalence and time course of maladaptive
personality traits in schizophrenia spectrum
disorders
K. Schroeder, UKE, Psychiatrie (Hamburg,
Germany)
A. Hoppe, B. Andresen, D. Naber, C. G. Huber
001
Exploring the use of repetitive peripheral
magnetic stimulation for studying pain perception in borderline personality disorder
A.-K. Fladung, Universität Ulm, Psychiatrie and
Psychotherapie (Ulm, Germany)
L. Cárdenas-Morales, T. Kammer, C. Schmahl,
P. Plener, B. Connemann, C. Schönfeldt-Lecuona
008
Gender differences in clinical presentation
and personality traits in Borderline Personality Disorder patients
S. Subirà, Universitat Autònoma Barcelona,
Psicologia Clínica i Salut (Bellaterra, Spain)
L. Ramos Ferraz, M. Vállez, E. Gelabert,
S. Rodriguez, P. Castellvi, R. Martín-Santos
30
= Deutsch = English
Poster Session
12.30 – 13.30 h // Foyer C 02
Topic 17: Neurobiology
Neurobiology
Chair: C. Schmahl (Mannheim, Germany)
002
Association analysis of brain-derived neurotrophic factor (BDNF) gene polymorphisms in
M. Muscionico, Hôpitaux Universitaires Genève,
Belle-Idée (Chêne-Bourg, Switzerland)
J. Lubbers, P. Huguelet, A. Malafosse,
N. Perroud
Thu
003
Imaging and measuring impulsivity
M. Röhl, Universität Oldenburg, Medizinische
Physik (Oldenburg, Germany)
S. Uppenkamp
004
Basal cortisol and cognitive functions in borderline personality disorder
S. Fernando, Ev. Krankenhaus Bielefeld, Klinik
für Psychiatrie (Bielefeld, Germany)
T. Beblo, N. Schlosser, K. Terfehr, B. Löwe,
O. T. Wolf, C. Spitzer, M. Driessen, K. Wingenfeld
005
Borderline Personality Disorder: Psychopharmacological therapeutical sugestions
I. Durán Cristobal, Hospital Ramón y Cajal,
Dept. of Psychiatry (Madrid, Spain)
A. Chinchilla, M. Vega, M. García, A. Cebollada,
R. Gomez, D. de la Vega Moreno
006
Association between low activity allele of
cathecolamine-O-methyl-transferase (COMT)
and Borderline Personality Disorder
G. de Vidovich, DSSAeP, Dept. of Psychiatry
(Pavia, Italy)
M. Lazzaretti, D. Fabbro, M. Sala, K. Del Toso,
F. Gambini, N. Morandotti, M. Balestrieri,
G. Damante, E. Caverzasi, P. Brambilla
007
Association study between five genes encoding dopaminergic receptors and borderline
personality disorder
A. Martín Blanco, Hospital de Sant Pau, Dept. of
J. C. Pascual, M. Ferrer Vinardell, Ó. AndiónPérez, J. Soler, M. Baiget, C. Sánchez-Mora,
J. A. Monreal, D. de la Vega Moreno, M. Casas
Brugué, V. Pérez
008
Clinical Correlations associated with low serotonergic function in patients with borderline
personality disorder and healthy control subjects
N. Schaaff, Ludwig-Maximilian University, Psychiatry and Psychotherapy (Munich, Germany)
W. Koch, K. Tatsch, M. Reicherzer, C. Ehmer-von
Geiso, S. Karch, H.-J. Moeller, O. Pogarell
009
Effects of emotional arousal on working memory in violent criminal offenders with Borderline Personality Disorder
L. Schulze, Freie Universität Berlin, Inst. für Klin.
Psychologie (Berlin, Germany)
K. Prehn, C. Berger, K. Vohs, M. Fleischer, K.
Hauenstein, P. Keiper, G. Domes, S. C. Herpertz
010
Neurophysiological correlates of reward pro
cessing in Borderline Personality Disorder
patients
D. de la Vega Moreno, Fundacio Idibell
(Hospitalet de Llobregat, Spain)
A. Soto, J. Amengual, R. Torrubia Beltri,
N. Frerich, J. Ribas, J. A. Monreal, R. de DiegoBalaguer, A. Rodriguez-Fornells, J. MarcoPallares
011
Dorsolateral prefrontal cortex and hippocampus sustain impulsivity and aggressiveness in
E. Caverzasi, University of Pavia, DSSAP,
Psychiatry (Pavia, Italy)
S. Michela, d. V. giulia, M. Lazzaretti, E. Maraffini, F. Gambini, N. Morandotti, P. Brambilla
Poster Session
P-004
12.30 – 13.30 h // Foyer C 02
Topic 6: Anxiety Disorder
Anxiety Disorder
Chair: U. Schweiger (Lübeck, Germany)
001
Eating disorders as a mechanism of affect
regulation in the borderline personality disordered client
S. M. Darker-Smith, Wrexham CAMHS
(Oswestry, Shropshire, United Kingdom)
002
Can Borderline Dimensional manifestations
increment the Use of Mental Health services
in adolescents with Eating Disorders?
E. Magallon Neri, University of Barcelona,
Personality Assesment (Barcelona, Spain)
G. Canalda, M. Forns, J. E. De la Fuente,
R. García, E. González, J. Castro-Fornieles
= Deutsch = English
31
Thu
003
Dialectical Behaviour Therapy in the treatment of borderline personality disorder and
Eating disorders: Preliminary results
M. V. Navarro Haro, (Castellon, Spain)
A. García Palacios, V. Guillen Botella, H. Marco,
E. Crespo, C. Botella Arbona
004
Different subgroups of adolescents patients
with anorexia nervosa
C. Zechowski, Institute of Psychiatry and Neurology (Warsaw, Poland)
I. Namyslowska, J. Bragoszewska, M. Prusik,
M. Witkowska
005
Affective instability and self-esteem in borderline personality disorder
S. Koudela, ZI für seelische Gesunheit (Mann
heim, Germany)
P. Santangelo, U. Ebner-Priemer
006
Attachment insecurity, negative mood symptoms and rejection expectancy among adults
with borderline and avoidant features
J. Drabble, Sheffield Hallam University, Dept. of
Psychology (Barnsley, United Kingdom)
D. Bowles, B. Meyer, J. Reidy, T. Bell
007
Electroconvulsive therapy (ECT) as an effective intervention for a patient with severe suicidal major depression and borderline personality disorder (BPD)
D. M. Gescher, LVR-Klinikum Düsseldorf,
Allgemeine Psychiatrie II (Düsseldorf, Germany)
A. Ruttmann, J. Malevani
008
Efficacy of therapy with Na valproate in depressed patients comorbid to Borderline Personality Disorder
M. Cvjetkovic-Bosnjak, KCV, Institute for Psychiatry, Clinical of Affective Disorder (Novi Sad,
Serbia)
B. Soldatovic-Stajic, R. Lisulov, A. Nedic,
J. Dadasovic, V. Vasic
32
= Deutsch = English
009
Mood fluctuations in patients with borderline
personality disorder, depression disorder and
a healthy control group in a psychophysiological study
A. Miro, Universität Hamburg, Institut für Psychologie (Hamburg, Germany)
B. Dahme
010
Lipids of blood and anxiety disorders: Effects
of interrelationship in assessment of cardiovascular risk
N. Garganeyeva, Siberian State Medical Univers
(Tomsk, Russia)
011
Feedbackprocessing in Borderline personality
disorder: Evidence for a subgroup vulnerable
for major depressive disorder
A.-K. Fladung, Universität Ulm, Psychiatrie and
Psychotherapie (Ulm, Germany)
I. Brosig, M. Kiefer
P-005
Poster Session
12.30 – 13.30 h // Foyer C 02
Topic 11: Emotion Regulation
Emotion Regulation
Chair: S. Röpke (Berlin, Germany)
001
Repeated 15-Minute Assertiveness Training
Sessions Reduce to a Certain Extent Wrist
Cutting In Patients with Borderline Personality Disorder
M. Hayakawa, The University of Tokyo, Dept. of
Psychiatry, (Tokyo, Japan)
002
A retrospective survey of inpatients admitted
between Jan 2009 – 2010, from Crawley / Horsham area (Uk), with a diagnosis of Emotionally Unstable Personality Disorder, Borderline
type (ICD 10 F60)
C. Gradillas, (Haywards Heath, United Kingdom)
C. Gil Rios
003
PRISM – The Development Of An Inpatient
Service Model For Women With Personality
Disorder
P. Stankard, Alpha Hospital (Sheffield, United
Kingdom)
Thu
004
Using plan analysis in psychotherapeutic case
formulation for Borderline Personality Disorder
L. Berthoud, Institut de Psychothérapie, Dept. de
Psychiatrie, CHUV (Prilly, Switzerland)
U. Kramer, Y. De Roten, J.-N. Despland,
F. Caspar
005
The effects of self-efficacy on dental Anxiety
and health care
S. Sud, St. Bede´s College, Dept. of Psychology
(Shimla, India)
N. Sud
006
An integrative psychotherapy intervention in
the Borderline Personality Disorder
L. Drobot, Eftimie Murgu University, Economic
and Administrative (Resita, Romania)
007
Reconstructing the Past: Constructivist Brief
Therapy of patient with Borderline Personality Disorder
E. Magallon Neri, University of Barcelona,
Personality Assesment (Barcelona, Spain)
A. Pérez, G. Feixas
008
Imagery grounding as a mechanism for affect
self-regulation
009
EMDR in the treatment of Borderline Personality Disorder (Addressing Abandonment)
Special Session
SP-001
13.30 – 15.00 h // Hall C 01
Opening Ceremony
Chair: M. Bohus (Mannheim, Germany)
001
Presidential Address – DGPPN
F. Schneider, Universitätsklinikum Aachen, Psychiatrie und Psychotherapie (Aachen, Germany)
002
Presidential Address – APA
J. Oldham, The Menninger Clinic, Psychiatry
and Behavioral (Houston, USA)
003
Welcome Address
M. Bohus, ZI für Seelische Gesundheit, Inst. für
Psychosomatik (Mannheim, Germany)
Practice Seminar
PS-105
15.15 – 18.15 h // Hall B 09
Early intervention for borderline personality
disorder in youth
A. Chanen (Melbourne, Australia)
L. McCutcheon (Parkville, Australia)
Practice Seminar
PS-106
15.15 – 18.15 h // Hall B 7/8
Adolescent Identity Treatment: A new approach to identifying and treating personality
pathology in adolescence
P. Foelsch (Harrison, USA)
K. Schmeck (Basel, Switzerland)
Practice Seminar
PS-107
15.15 – 18.15 h // Hall A 03
Topic 24: Schema Therapy
Workshop Schema Therapy for Borderline
A. Arntz (Maastricht, The Netherlands)
G. Jacob (Freiburg, Germany)
= Deutsch = English
33
Thu
Practice Seminar
PS-108
15.15 – 18.15 h // Hall A 04
Topic 1: ADHD
Treatment of comorbid ADHD in patients
with BPD
A. Philipsen (Freiburg, Germany)
Practice Seminar
PS-109
15.15 – 18.15 h // Hall A 05
Topic 23: PTSD
Dialectical Behavior Therapy for Posttrauma
tic Stress Disorder (DBT-PTSD) after childhood sexual abuse: A new treatment
R. Steil (Frankfurt, Germany)
A. Dyer (Mannheim, Germany)
Practice Seminar
PS-110
15.15 – 18.15 h // Hall A 06
Topic 1: ADHD
Behandlung komorbider AD(H)S bei Patien
ten mit Borderline-Persönlichkeitsstörung
H. Richter (Freiburg, Germany)
Practice Seminar
PS-111
15.15 – 18.15 h // Room B 03
Topic 10: Eating Disorders
DBT-Essstörung
U. Schweiger (Lübeck, Germany)
OP-001
Oral Presentation
15.15 – 16.45 h // Hall C 01
Topic 21: Psychodynamically Informed
Psychiatric Care
Diagnostics
Chair: S. McMain (Toronto, Canada)
Co-Chair: T. Rinne (Utrecht, The Netherlands)
001
Symptoms of Affective and Anxiety Disorder
and Borderline Personality Disorder
J. Coid, Queen Mary UoL, Forensic Psychiatry
Research (London, United Kingdom)
002
The psychometric properties of the German
version of the Borderline Personality Disorder
Severity Index — Version IV
C. Kröger, Tech. Universität Braunschweig, Inst.
für Psychologie (Braunschweig, Germany)
M. Vonau, S. Kliem, S. Röpke, A. Arntz
003
Severity of personality functioning among patients with borderline personality disorder:
Results from the Severity Indices for Personality Problems (SIPP)
H. Andrea, De Viersprong, VISPD (Halsteren,
The Netherlands)
R. Verheul
004
A Short Version of the Kentucky Inventory of
Mindfulness Skills (KIMS)
V. Höfling, Goethe University (Frankfurt, Germany)
G. Ströhle, J. Michalak, T. Heidenreich
005
The Structure of Borderline Personality Symptoms: A Comprehensive Investigation in an
Outpatient Psychiatric Sample
L. Quilty, CAMH (Toronto, Canada)
R. Paxton, S. McGee Ng, R. M. Bagby
006
Defining general personality disorder: Differentiating personality disorder from both normal personality and other psychiatric disorders
A. G. Hentschel, SKH Großschweidnitz,
Institutsambulanz (Weißwasser, Germany)
J. W. Livesley
34
= Deutsch = English
Thu
OP-002
Oral Presentation
15.15 – 16.45 h // Hall B 5/6
Topic 1: ADHD
Comorbidity
Chair: P. Tyrer (London, United Kingdom)
Co-Chair: A. Ivanoff (New York, USA)
001
Comorbid Attention-Deficit / Hyperactivity Dis
order in Borderline Personality Disorder: De
finition of an impulsive BPD subtype
M. Ferrer Vinardell, Hospital Vall d‘Hebron,
Dept. of Psychiatry (Barcelona, Spain)
Ó. Andión-Pérez, M. Casas Brugué
002
Borderline Personality Disorder features,
drinking motives and alcohol problems
S. Tragesser, Washington State University, Dept.
of Psychology (Richland, USA)
R. J. Robinson
003
Achtsamkeits- versus Fertigkeitentraining bei
Erwachsenen mit ADHS
M.-A. Edel, LWL-Universitätsklinik, Psychiatrie
und Psychotherapie (Bochum, Germany)
T. Hölter
004
Risk factors for suicide in BPD – A Prospective Study
B. Brodsky, Columbia University, Dept. of
Psychiatry (New York, USA)
S. Wilson, R. Richardson, E. Fertuck, B. Stanley
005
ADHD-Komorbidität bei Borderline-Patientinnen in einer RCT-Studie
P. Martius, Höhenried gGmbH DRV Bayern-Süd,
Abt. Psychosomatik (Bernried, Germany)
S. Hörz, M. Rentrop
006
Physical health in patients with Borderline
K. G. Kahl, Medizin. Hochschule Hannover, Inst.
für Psychiatrie (Hannover, Germany)
Oral Presentation
OP-003
15.15 – 16.45 h // Hall A 01
Psychiatric Care
Single Cases and Treatment
Chair: T. Kienast (Hamburg, Germany)
Co-Chair: C. Maffei (Milan, Italy)
001
Convergences of outcome and neural correlate in the psychodynamic treatment of borderline disorder
C. Lai, University of Rome, Dept. of Clinical
Psychology (Rome, Italy)
S. Daini, M. L. Calcagni, I. Bruno, M. Cecchini
002
Is Dissociation the core in Borderline Personality Disorder?
J. Haliburn, Mental Health Sciences Centre,
Westmead & Cumberland Hospital (Parramatta,
NSW, Australia)
003
Stability of borderline personality disorder
from childhood to adulthood: a literature review
P. Deschamps, Utrecht University Hospital,
Child- & Adolescent Psychiat. (The Netherlands)
004
Music Therapy for Patients with Borderline
G. Strehlow, Bethesda-Allgemeines, Kranken
haus Hamburg Bergedorf (Hamburg, Germany)
005
Mentalization Based Treatment for adolescents: A challenge in the therapy. Emergent
BPD by adolescents: Early treatment prevents
the development of severe personality disorders in the II and III decade of life
D. Balanzin, Office Médico Pédagogique, Dept.
Pathology and Medicine (Geneva, Switzerland)
006
Borderline Personality Disorder – Narrative
Identity Deficiency
A. Nirestean, (Corunca, Romania)
M. Ardelan, D. Cimpan
= Deutsch = English
35
Thu
Oral Presentation
OP-004
OP-005
Oral Presentation
16.45 – 18.15 h // Hall C 01
Topic 12: Epidemiology
Etiology
Chair: A. S. New (Bronx, USA)
Co-Chair: S. Torgersen (Oslo, Norway)
16.45 – 18.15 h // Hall B 5/6
Adolescents
Chair: F. Resch (Heidelberg, Germany)
Co-Chair: K. von Auer (Lübeck, Germany)
001
Genetic and environmental influences on Borderline Personality Disorder: An item-factor
approach
T. Reichborn-Kjennerud, Norwegian Institute of
Public, Mental Health (Oslo, Norway)
E. Ystrom, K. Kendler
001
DBT bei essgestörten Jugendlichen – Erfah
rungen aus einem ambulanten Therapieprojekt
C. Thurn, (Berlin, Germany)
H. Salbach-Andrae, E. Pfeiffer, U. Lehmkuhl
002
Prenatal Adversity – A potential Risk Factor in
C. E. Schwarze, Universitätsmedizin Mainz, Psychiatrie und Psychotherapie (Mainz, Germany)
A. Mobascher, D. H. Hellhammer, K. Lieb
003
Age as a predictor of symptomatology, co-occurring psychiatric disorders and socio-economic characteristics in patients with BPD
N. Kleindienst, ZI für Seelische Gesundheit, Psychosomatische Medizin (Mannheim, Germany)
M. Limberger, M. Bohus
004
Early traumatic life events in borderline personality disorder
M. Limberger, ZI für Seelische Gesundheit, Inst.
für Psychosomatik (Mannheim, Germany)
N. Kleindienst, M. Bohus
005
Maternal transmission of borderline personality disorder (BPD): A prospective communitybased cohort study
E. Arens, Universität Heidelberg, Klinische
Psychologie (Heidelberg, Germany)
S. Barnow
006
Borderline Personality Disorder and the emotional quality of youth memories
C. Schotte, UZ Brussel, Dienst Klinische Psychologie (Brussels, Belgium)
36
= Deutsch = English
002
Childhood experiences of care and abuse in a
clinical sample of self-harming and suicidal
adolescents
M. Kaess, Med. Universität Heidelberg, Kinderund Jugendpsychiatrie (Heidelberg, Germany)
P. Parzer, M. Mattern, F. Resch, R. Brunner
003
Borderline Personality Disorder (BPD) in Suicidal Adolescents
S. Yen, Brown Medical School, Psychiatry and
Human Behavior (Providence, USA)
004
Do borderline and control female adolescents
experience emotional awareness differently
depending on their experience of depression?
D. Van Den Bulke, Université Bordeaux 2
(Bordeaux, France)
O. Onorato, O. Guibauld, S. Bydlowski-Aidan,
C. Dugré Le Bigre, M. Robin, C. Lamas,
A. Pham, M. Speranza, M. Corcos
005
Affective lability and anger in adolescent Borderline Personality Disorder
C. Huynh, Rivière-des-Prairies Hospital, Mood
Disorders Clinic (Montreal, Canada)
J.-J. Breton, L. Desrosiers, N. Bodeau, D. Cohen,
J.-M. Guilé
006
The prevalence of personality disorders in
adolescent in-patients
M. Krischer, Universitätsklinik Köln, Kinder- und
Jugendpsychiatrie (Cologne, Germany)
K. Sevecke
Thu
OP-006
Oral Presentation
16.45 – 18.15 h // Hall A 01
Experimental Psychopathology
Chair: E. Coccaro (Chicago, USA)
Co-Chair: T. Kienast (Hamburg, Germany)
001
Emotional Stroop for Bordeline Personality
Disorder patients
P. A. Schmidt Do Prado-Lima, (Porto Alegre,
Brazil)
V. Dornelles, R. Grassi-Oliveira, C. Kristensen
003
Theory of mind and borderline personality
disorder: evidence for a deficit on mental
state reasoning
A.-H. Moncany, CHU Purpan Casselardit, Psychiatrie (Toulouse, France)
L. Cailhol, E. Bui, A. Mathur, J. Grèzes,
L. Schmitt, P. Birmes
004
Impulsivity in youth diagnosed with Borderline Personality Disorder: Reward-based decision-making and its relationship to emotional
distress
K. Lawrence, (Thatcham, United Kingdom)
J. S. Allen, A. Chanen
Symposium
S-007
18.30 – 20.00 h // Hall B 5/6
Emotional Dysregulation in Borderline Personality Disorder
Chair: S. C. Herpertz (Heidelberg, Germany)
001
Dysregulated Networks in the Cognitive Control of Emotion in Borderline Personality Disorder
H. Koenigsberg, Mount Sinai School of Medicine,
Dept. of Psychiatry (New York, USA)
J. Fan, K. Ochsner, X. Liu, M. Goodman,
A. S. New, L. Siever
002
Central and peripheral emotional responses
in BPD and effects of psychotherapy
A. Arntz, University of Maastricht, Clinical Psychological Science (Maastricht, The Netherlands)
003
Affect regulation and pain in borderline personality disorder: a possible link to the understanding of self-injury
I. Niedtfeld, Central Institute for Mental Health
(Mannheim, Germany)
C. Schmahl
004
Neural correlates of humor and emotion
processing and impact of childhood stress in
patients with borderline disorder and major
depression
T. Frodl, Trinity Hospital (Heidelberg, Germany)
A. Samson, A. Carballedo, A. O`Grady-Walsh,
Y. Fergusson, I. Daly, G. Connolly
= Deutsch = English
37
Thu
Symposium
S-008
18.30 – 20.00 h // Hall A 01
Topic 3: Aggression
Facets of Impulsivity in BPD
Chair: O. Tüscher (Freiburg, Germany)
Co-Chair: A. S. New (Bronx, USA)
001
Impulsive aggression in BPD patients with
and without intermittent explosive disorder
A. S. New, Mount Sinai School of Medicine,
Dept. of Psychiatry (Bronx, USA)
E. Rich, E. A. Hazlett, M. Goodman,
H. Koenigsberg, L. Siever
002
Neural correlates of financial decision making
in criminal offenders with psychopathy and
K. Prehn, Freie Universität Berlin, Psychiatrie
und Psychotherapie (Berlin, Germany)
S. Herpertz
003
Impulsivity under stress and non-stress conditions in BPD with and without comorbid
ADHD
A. Krause-Utz, ZI für Seelische Gesundheit,
Psychosomat. Medizin (Mannheim, Germany)
E. Sobanski, B. Alm, N. Kleindienst, M. Bohus,
C. Schmahl
004
Neutral and emotionally modulated behavioral inhibition in BPD
A. Sebastian, K. Bader, G. Jacob, K. Lieb
Practice Seminar
PS-112
18.30 – 20.00 h // Hall A 03
Schema Mindfulness-based cognitive therapy (MBCT): How to incorporate mindfulness
in schematherapy?
M. van Vreeswijk (Delft, The Netherlands)
38
= Deutsch = English
PS-113
Practice Seminar
18.30 – 20.00 h // Hall A 04
Topic 16: Mentalization Based Therapy
How to manage attachment trauma in border
line patients by Mentalization-Based Treatment: Therapeutical relationship and setting
T. Bolm (Zeist, The Netherlands)
PS-114
Practice Seminar
18.30 – 20.00 h // Hall A 05
Clinical use of attachment interviews in the
diagnostics of Borderline Personality Disorders
A. Buchheim (Innsbruck, Austria)
PS-115
Practice Seminar
18.30 – 20.00 h // Hall A 06
A framework for the treatment of the difficult
to treat person with severe personality disorders and substance use disorder
A. Dijkhuizen (Eindhoven, The Netherlands)
PS-116
Practice Seminar
18.30 – 20.00 h // Room B 03
Einführung in das Skillstraining
P. Zimmermann (Berlin, Germany)
J. Murat (Stuttgart, Germany)
OP-007
Oral Presentation
18.30 – 20.00 h // Hall C 01
Symptom Assessment
Chair: C. Maffei (Milan, Italy)
Co-Chair: U. Schweiger (Lübeck, Germany)
001
Disorder Specificity of Aversive Tension and
Dissociation in Borderline Personality Disorder – a Computer-Based Controlled Field
Study
C. Stiglmayr, AWP-Berlin (Berlin, Germany)
M. Mohse, R. Behm, T. Gooren, J. Stecher-Mohr,
T. Fydrich, M. Bohus
Thu
002
Processes of self-harm reduction and personally-defined recovery in borderline personality disorder (BPD)
C. Katsakou, Newham DBT Team, East London
NHS Trust (London, United Kingdom)
S. Marougka, K. Barnicot, N. Fearns, A. Gaglia,
S. Priebe
003
Auditory verbal hallucinations in borderline
personality disorder; phenomenology and distress in comparison to patients with schizophrenia
C. Slotema, Parnassia Bavo Psychiatric, Institute
(The Hague, The Netherlands)
J. D. Blom, I. Sommer, W. Hoek
004
Qualitative movement behaviour and body
image of patients with Borderline Personality
Disorder
A. Degener, Techn. Universität Dortmund, Rehabilitationswissenschaften (Dortmund, Germany)
005
Emotion regulation in samples of psychiatric
patients with and without Borderline Personality Disorder
J. Hansen, Psychiatric Center Glostrup,
Psykologenheden, P79 (Glostrup, Denmark)
B. Henning, P. Lorentzen
006
A PET-FDG scan study of olanzapine treatment in Borderline Personality Disorder
C. Schulz, University of Minnesota, Dept. of
Psychiatry (Minneapolis, USA)
J. Camchong, A. Romine, M. Kuskowski,
J. Pardo, K. Cullen, K. Lim
Oral Presentation
OP-008
18.30 – 20.00 h // Hall B 7/8
Psychodynamic Cases
Chair: J. Clarkin (White Plains, USA)
Co-Chair: S. Doering (Münster, Germany)
001
Moments and factors of change in the psychoanalytic psychotherapy of patients with Borderline Personality Disorder
M. Keinanen, Finnish Student Health Service,
Dept. of Mental Health (Turku, Finland)
E. Aarela, K. Eerola, P. Niemelä, S. Seppanen
002
Treatment by integrative psychotherapy of a
L. Drobot, Eftimie Murgu University, Economic
and Administrative (Resita, Romania)
003
Confusion of tongues today. Is Borderline
Personality Disorder etiquette for masking
PTSD?
C. Zechowski, Institute of Psychiatry and
Neurology (Warsaw, Poland)
004
Cognitive-affective impairment in BPD: Outcome of long-term transference-focused
psychotherapy of two cases valued with
WAIS-R Scale and Rorschach Comprehensive
System’s Ego Impairment Index-2
S. Ongarato, Hospital of ULSS10, San Dona di
Piave-Venezia- (Treviso, Italy)
M. DallÁsta, E. Russino
005
Fear at the coalface: Power dynamics in life
threatening self-harm behaviours in borderline personality disorder
J. Beatson, Eastern Health, Personality Disorder
Service (Ringwood East, Australia)
= Deutsch = English
39
Thu
Oral Presentation
OP-009
18.30 – 20.00 h // Hall B 09
Topic 12: Epidemiology
Psychotherapy Trials
Chair: P. Links (Toronto, Canada)
Co-Chair: A. Philipsen (Freiburg, Germany)
001
Treatment completion in psychotherapy for
borderline personality disorder: A systematic
review and meta-analysis
K. Barnicot, Queen Mary University London,
Social & Community Psychiatry (London, United
Kingdom)
C. Katsakou, S. Marougka, S. Priebe
002
Family Interventions: Improving Outcomes for
Patients and Family Members
A. Fruzzetti, University of Nevada, Dept. of Psychology (Reno, USA)
003
Effects of motive-oriented therapeutic relationship in early treatment phase for borderline personality disorder: A randomized controlled trial
U. Kramer, CHUV Lausanne, Inst. of Psycho
therapy (Lausanne, Switzerland)
S. Kolly, M. Preisig, Y. De Roten, J.-N. Despland,
F. Caspar
40
= Deutsch = English
004
Effectiveness of outpatient, day hospital, and
inpatient psychotherapeutic treatment for patients with borderline and other cluster B personality disorders
A. Bartak, VISPD (Amsterdam, The Netherlands)
H. Andrea, M. D. Spreeuwenberg, E. Hamers,
J. J. V. Busschbach, R. Verheul, T. Stijnen,
P. M. G. Emmelkamp
005
A randomized clinical trial of psychoanalytic
psychotherapy and enhanced treatment as
usual among borderline patients in a suicidal
crisis
A. Andreoli, Hôpitaux Univ. de Genève (HUG),
Dept. de Psychiatrie (Geneva, Switzerland)
L. Frambati, P. Ohlendorf, T. Di Clemente,
Y. Burnand
006
Traumatic mourning focused psychoanalytic
psychotherapy (TMFPP) for borderline patients in a suicidal crisis: Rationale, technique
and process measures
Y. Burnand, Hôpital Cantonal, Dépt. de Psychiatrie (Geneva, Switzerland)
S. Lorillard, M. Sartori, A. Andreoli
Fri
S-009
Symposium
09.00 – 10.30 h // Hall C 01
Topic 23: PTSD
Treatment of Posttraumatic Stress Disorder
in patients suffering from Borderline Personality Disorder
Chair: R. Steil (Frankfurt, Germany)
Co-Chair: A. Dyer (Mannheim, Germany)
001
Treating PTSD in High-Risk Clients with Borderline Personality Disorder: Dialectical Behavior Therapy plus an Exposure-Based PTSD
Protocol
M. Linehan, University of Washington, Dept. of
Psychology (Washington, USA)
002
Dialectical-Behavior-Therapy for Borderline
Personality Disorder with Severe Posttrauma
tic Stress Disorder after Childhood Sexual
Abuse: Rationale, Concept and Structure of an
Intensive Residential Treatment Program
M. Bohus, ZI für Seelische Gesundheit, Inst. für
A. Dyer, K. Priebe, A. Krüger, R. Steil
003
Dialectical-Behavior-Therapy for Severe Posttraumatic Stress Disorder after Childhood Sex
ual Abuse: A Randomized Controlled Trial
R. Steil, Universität Frankfurt, Klinische Psychologie (Frankfurt, Germany)
A. Dyer, K. Priebe, A. Krüger, M. Bohus
004
Impaired sexual function in patients with borderline personality disorder is determined by
history of sexual abuse
O. Schulte-Herbrueggen, Charité Berlin, Inst. für
C. J. Ahlers, A. Rüter, S. Bahri, A. Vater, S. Röpke
Symposium
S-010
09.00 – 10.30 h // Hall B 5/6
Dissoziation – Neurobiologische Mechanismen und therapeutische Implikationen
Co-Chair: C. Spitzer (Hamburg, Germany)
001
Phänomenologie von Dissoziation und Bedeutung für die Psychotherapie
C. Spitzer, UKE Hamburg-Eppendorf, Psychoso
matische Medizin (Hamburg, Germany)
002
Neurobiologische Korrelate von Dissoziation
C. Schmahl, ZI für Seelische Gesundheit, Psychosomatische Medizin (Mannheim, Germany)
P. Ludäscher, J. Mauchnik, M. Bohus
003
Dissoziation und Dialektisch-Behaviorale Psy
chotherapie
004
Therapeutische Optionen bei Dissoziation
C. Stiglmayr, AWP-Berlin (Berlin, Germany)
Symposium
S-011
09.00 – 10.30 h // Hall B 7/8
Transference-Focused psychotherapy: State
of the art
Chair: J. Clarkin (White Plains, USA)
Co-Chair: P. Buchheim (Munich, Germany)
001
Neurocognitive functioning of borderline patients: Implications for patient selection and
treatment
J. Clarkin, Weill Cornell Medical College, Dept. of
Psychiatry (White Plains, USA)
002
Outcome beyond symptoms in TransferenceFocused Psychotherapy
S. Hörz, LMU München, Department Psycholo
gie (Munich, Germany)
= Deutsch = English
41
Fri
003
Outcome studies on TFP
S. Doering, Universitätsklinikum (Münster,
Germany)
004
Recent Developments in Transference-Focused
Psychotherapy
F. Yeomans, (USA)
Symposium
S-012
09.00 – 10.30 h // Hall B 09
Biological studies and considerations in borderline personality disorder
Chair: K. Silk (Ann Arbor, USA)
Co-Chair: T. Rinne (Utrecht, The Netherlands)
001
Impaired habituation to positive and negative
emotional stimuli in BPD: An fMRI and psychophysiology study
E. A. Hazlett, M. Goodman, H. Koenigsberg,
L. Siever
002
Borderline personality disorder and substance
use: genetic analyses of comorbidity
M. Distel, VU University Amsterdam, Dept. of
Psychiatry (Amsterdam, The Netherlands)
M. C. Neale, G. Willemsen, J. Vink, T. Trull,
C. Derom, D. Boomsma
003
The Impact of IL-18 and Neuroticism on Regional Endogenous Opioid Functioning in
A. R. Prossin, University of Michigan, Dept. of
Psychiatry (Ann Arbor, USA)
004
Antidepressant therapy: A possible strategy
for the prevention of stress related disorders
in traumatized borderline patients
T. Rinne, Netherlands Institute of For., Dept. of
Psychiatry (Utrecht, The Netherlands)
42
= Deutsch = English
S-013
Symposium
09.00 – 10.30 h // Hall A 01
Adolescence and borderline personality: Experience from a European french-speaking
research network
Chair: M. Corcos (Paris, France)
Co-Chair: A. Pham-Scottez (Paris, France)
001
Factor analysis of DSM-IV borderline personality disorder criteria in adolescence: results
from the European Research Network on Borderline Personality Disorder (EURNET BPD)
M. Speranza, Centre Hospital. de Versailles,
INSERM U669 (Le Chesnay, France)
A. Pham-Scottez, F. Perez-Diaz, M. Corcos
002
Suicide attempts in teenagers with a borderline personality disorder. Preliminary results
from the European Research Network for Borderline Personality (EURNET BPD)
V. Delvenne, Université Libre de Bruxelles,
ETEAP (Brussels, Belgium)
P. Abadie
003
Quality of childhood in adolescents developing early borderline personality disorder:
preliminary results from the EURNET BPD
(European Network on Borderline Personality
Disorder)
M. Douniol, (Paris, France)
004
Lower sensitivity to facial expressions of anger and happiness in adolescents with a borderline personality disorder
M. Robin, Institut Mutualiste Montsouris (Paris,
France)
S. Berthoz, A. Pham-Scottez, G. Kedia, F. Curt,
C. Dugré Le Bigre, M. Corcos
Fri
PS-117
Practice Seminar
09.00 – 10.30 h // Hall A 03
Umgang mit Grenzen und Kontingenzen in
der ambulanten und stationären DBT
F. Leihener (Uster, Switzerland)
PS-118
Practice Seminar
09.00 – 10.30 h // Hall A 04
Group Schema Therapy for Borderline Personality Disorder: Model, Therapist Style,
Core Techniques and Empirical Validation
J. Farrell (Indianapolis, USA)
I. Shaw (Indianapolis, USA)
PS-119
Practice Seminar
09.00 – 10.30 h // Hall A 05
DBT in der Tagesklinik – Zwei Modelle
S. Alff-Petersen (Wiesbaden, Germany)
R. Markus (Cologne, Germany)
PS-120
Practice Seminar
09.00 – 10.30 h // Hall A 06
Wie vermittele ich Achtsamkeit?
U. Rathjen (Bremen, Germany)
C. Prass (Bremen, Germany)
PS-121
Practice Seminar
09.00 – 10.30 h // Room B 03
Topic 23: PTSD
Schematherapie bei Borderline Persönlich
keitsstörung
N. Reiss (Mainz, Germany)
F. Vogel (Mainz, Germany)
PL-003
Plenary Session
11.00 – 11.45 h // Hall C 01
Epigenetics in the control of behavior
Moshe Szyf, McGill University, Pharmacology
and Therapeutics (Montreal, Canada)
Moderation: Ulrich Schweiger (Lübeck,
Germany)
Plenary Session
PL-004
11.45 – 12.30 h // Hall C 01
Neurobiological Findings in Borderline Personality Disorders – State of the Art
Sabine C. Herpertz, Universität Heidelberg,
Klinik für Allgem. Psychiatrie (Heidelberg,
Germany)
Moderation: Christian Schmahl (Mannheim,
Germany)
Poster Session
P-006
12.30 – 13.30 h // Foyer C 02
Dialectical Behavioural Therapy
Chair: L. Dimeff (Seattle, USA)
001
Self-Reported Emotional Dysregulation But
No Impairment of Emotional Intelligence in
T. Beblo, Ev. Krankenhaus Bielefeld (Bielefeld,
Germany)
A. Pastuszak, J. Griepenstroh, S. Fernando, M.
Driessen, A. Schütz, K. Rentzsch, N. Schlosser
002
Effects of a dialectical behavioural skills training group: a naturalistic study in an outpatient
centre
V. Salamin, Réseau Fribourgeois de Santé
Mentale (RFSM) (Marsens, Switzerland)
F. Guenot, O. Clément, S. Medzihradska,
A. Kratzel
003
The concurrent use of Dialectical Behavior
Therapy and analytically oriented psychotherapy in a hospital setting for Borderline Personality Disorder
P. Milák, (Budapest, Hungary)
K. Horváth, J. Harmatta
004
Head in the sun and feet in the mud: the challenge of implementing the dialectical model
in clinical practice
P. Haake, UPC K.U.Leuven, Conitive Behavioural
Therapy (Kortenberg, Belgium)
= Deutsch = English
43
Fri
005
Efficacy of mindfulness in the improvement of
impulsivity in patients with Borderline Personality Disorder
A. Valdeperez, Hospital de Sant Pau, Dept. of
J. Soler, J. C. Pascual, A. Feliu, A. Martín Blanco,
E. Álvarez, V. Pérez Sola
006
Mediating and moderating processes in mindfulness interventions: The proposition of an
evidence-based model
A. van Randenborgh, Eos-Klinik für Psychothera
pie (Münster, Germany)
J. Hüffmeier
011
Dialectical behavioural therapy in patients
with borderline personality disorder who selfharm: a pragmatic exploratory trial
K. Barnicot, Queen Mary University London,
Social & Community Psychiatry (London, United
Kingdom)
C. Katsakou, S. Priebe, S. Marougka, N. Fearns
P-007
Poster Session
12.30 – 13.30 h // Foyer C 02
Substance Use Disorders
007
Dialectical Behavior Therapy in the real world:
An experience of integration into public community mental health services in Barcelona
I. Alvarez Tomas, CHM Les Corts, CSMA
Sarria-St.Gervasi (Barcelona, Spain)
E. Sánchez, M. Teixidó, M. San Emeterio
001
Personality disorders and substance misuse
in a sample of prison inmates
E. Preti, Università di Milano-Bicocca, Dept. of
A. Prunas, F. Lollo, R. Giove, G. Bertelli,
D. Barbini, F. De Martinis, F. Madeddu
008
Effectiveness of an adapted individual Dialectical Behaviour Therapy (DBT) compared to
the standard version: A preliminary results
B. Gancedo Villegas, Hospital Vall d´Hebron,
Servei de Psiquiatría (Barcelona, Spain)
Ó. Andión-Pérez, N. Calvo Piñero, M. Ferrer
Vinardell, C. Barral Picado, A. Di Genova,
M. Casas Brugué
002
Aggression and personality in addiction patients
K. M. Bayer, Med. Universität Graz, Addiction
Research Society/ARS (Graz, Austria)
H.-F. Unterrainer, S. Wallner-Liebmann,
N. Lackner
009
Dialectical Behavioural Therapy skills training group for borderlines outpatients: Adapted three months format
A. Soto Lumbreras, Fundacio Idibell (Hospitalet
de Llobregat, Spain)
M. Castells, D. de la Vega Moreno, J. Ribas,
D. Sánchez
010
Psychotherapygenetics: Do genes influence
psychotherapy adherence?
A. Martín Blanco, Hospital de Sant Pau, Dept, of
J. C. Pascual, J. Soler, T. Tiana, A. Valdeperez,
A. Feliu, V. Perez Sola
44
= Deutsch = English
003
Personality structure in the context of addictive disorder
N. Lackner, Medizin. Universität Graz, Addiction
Research Society (Graz, Austria)
H.-F. Unterrainer, K. M. Bayer, S. WallnerLiebmann, A. Neubauer
004
Addictive problems of studying youth in a
Siberian city
N. Bokhan, Mental Health Research Institute of
Addictive States (Tomsk, Russia)
005
Eating behavior and personality in addicts
and healthy controls
K. Kilzer, Medizin. Universität Graz, ARS
Addiction Research Society (Graz, Austria)
H.-F. Unterrainer, K. M. Bayer, S. Leopold,
N. Lackner, M. Hanschek, N. Allard, B. Poncza,
P. Pürstner, C. Neuper, S. Wallner-Liebmann
Fri
006
The therapeutic management of substance
users with Comorbid borderline Personality
Disorder in an outpatient individual program
for drug addiction treatment
L. Iliopoulou, (Ioannina, Greece)
V. Koutras, A. Fotiadou, E. Fidi, K. Komninou,
S. Gonta, V. Basogianni
003
A female patient with Borderline Personality
Disorder at the psychoanalytically oriented
department for psychotherapy: A clinical
case
B. Avgustin Avcin, University Psychiatr. Hospital,
Unit for Psychotherapy (Ljubljana, Slovenia)
A. Jelicic
007
Clinical features and differences of patients
with Borderline Personality Disorder in a residential structure for dual diagnosis
G. Savio, IRCCS Fatebenefratelli, Comunità
Doppia Diagnosi (Orzinuovi, Italy)
J. Pankok
004
A case presentation: The Adult Psychiatrist‘s
role in managing a client with Borderline personality disorder
T. Jha, NHS,Greater Manchester West, Dept. of
Psychiatry (Manchester, United Kingdom)
S. Amin
008
Anxiety and stress-coping in addiction patients
S. Leopold, (Graz, Austria)
005
An investigation of therapists’ factors regarding the dropout rate of a guideline-based
psychotherapy for Borderline Personality Disorder
M. Asano, Fujita Health University, Dept. of
Psychiatry (Toyoake, Japan)
K. Esaki, H. Kimura, K. Miyahara, T. Kitajima,
E. Kamiya, Y. Narita, N. Ozaki, N. Iwata
009
Dimensions of religious / spiritual well-being:
a comparison study between addicts and
healthy controls
H.-F. Unterrainer, Med. Universität Graz,
Addiction Research Society (Graz, Austria)
K.-H. Ladenhauf, S. Wallner-Liebmann, A. Fink
P-008
Poster Session
12.30 – 13.30 h // Foyer C 02
Psychiatric Care
Psychodynamically Informed Psychiatric Care
Chair: I. Daig (Berlin, Germany)
001
Effecttiveness of in-patient heterogeneous
groups in the treatment of Borderline Personality Disorder
B. Avgustin Avcin, University Psychiatr. Hospital,
Unit for Psychotherapy (Ljubljana, Slovenia)
M. Radovanovic, M. Lunacek
002
Intensive Dynamic Brief Group Therapy in a
Day Unit for Patients with Borderline Personality Disorder
C. Maruottolo, AMSA, Day Unit (Bilbao, Spain)
A. Mascaró, J. M. Galletero
006
Working in the psychiatric institution with
MBT: the supervision between analytic listening and educational goal
E. Caverzasi, University of Pavia, DSSAP, Psychiatry (Pavia, Italy)
O. Oasi
007
Preliminary results of 2 years Mentalization
Based Treatment of Borderline patients
C. Freund, Aarhus Universiteteshospital, Clinic
for Personal. Disorder (Risskov, Denmark)
R. Boeye, H. Blaabjerg, M. Kjoelbye,
C. R. Joergensen
008
Observational study on subgroups of borderline personality disorder: different longitudinal patterns in patients with panic attacks
E. Caverzasi, University of Pavia, DSSAP,
Psychiatry (Pavia, Italy)
D. Broglia, N. Morandotti, I. Camozzo,
V. Ferretti, S. Villani, A. Ramati, E. Rampi,
G. de Vidovich, O. Oasi, d. v. giulia
= Deutsch = English
45
Fri
009
The effects of locus of control on job burn out
among adult instructors
M. A. Memar, Shahid Beheshti University
(Tehran, Iran)
M. Ghahramani, M. Yazdani Fard
Poster Session
P-009
12.30 – 13.30 h // Foyer C 02
Behandlungsentwicklung
Chair: M. Reicherzer (Bad Tölz, Germany)
001
Selbstwirksamkeitserwartung bei BorderlinePatientinnen hinsichtlich der eigenen Fertigkeiten bei starker innerer Spannung (Stresstoleranz-Skills)
M. Wolf, Universitätsklinikum Tübingen, Abt. für
Psychiatrie (Tübingen, Germany)
T. Grathwol, R. Schaletzky, S. Wekenmann
002
Zur systemischen Therapie bei Persönlich
keitsstörungen
H. Kilian, BTZ Rhein-Neckar, Geschäftsführung
(Wiesloch, Germany)
003
ICD-10 Symptomprofile von Borderline-Pa
tientInnen mit und ohne Sozialphobie im Vergleich
J. Mrose, Uniklinik Dresden, Psychosomatik &
Psychotherapie (Dresden, Germany)
R. Noack, A. Keller, P. Joraschky
007
The integrative DBT treatment module in the
psychiatric-psychotherapeutic day clinic – A
redevelopment
C. Richter, Vivantes Wenckebach-Klinikum, Psychiatrie und Psychotherapie (Berlin, Germany)
008
DBT in komplementären Institutionen –
Skillsgruppen bei prowo Berlin
B. Wohl, PROWO Berlin (Berlin, Germany)
009
Die Verwendung von Bildern und Symbolen
bei der Umsetzung der DBT für Borderline
PatientInnen in einer Allgemeinpsychiatri
schen Tagesklinik
M. Krüger, Tagesklinik Friedrichshafen, Psychiatrie und Psychotherapie (Friedrichshafen,
Germany)
P-010
Poster Session
12.30 – 13.30 h // Foyer C 02
Adolescence
Chair: V. Sipos (Lübeck, Germany)
001
Adult Children of BPD and Online Message
Board Communications: Why does misery
love company?
S. Sulzer, University of Wisconsin (Madison, USA)
004
Kunstausstellung „tales of a borderline“
I. Apfalter, (Südstadt, Austria)
002
Educational discontinuity of borderline adolescents
M. Jeannot, Clinic Georges Heuyer (Paris, France)
L. Cailhol, M. Speranza, F. Perez-Diaz
005
Differenzierung des stationären DBT-Programms unter Berücksichtigung des regio
nalen Versorgungsauftrages im Zürcher Ober
land. DBT-orientiertes Kurzprogramm
P. Peiler, Clienia Schlössli AG, Erwachsenenpsy
chiatrie (Oetwil, Switzerland)
C. Schmid, K. Eisenhardt
003
The influence of Attention-Deficit Hyperac
tivity Disorder on the clinical presentation of
female adolescents with a Borderline Personality Disorder
A. Pham-Scottez, F. Perez-Diaz, M. Corcos
006
Genderorientierung in der stationären DBTA?
S. Lieb, Pfalzklinikum, Pfalzinstitut (Klingenmün
ster, Germany)
S. Anker
004
The differential diagnosis of Attention-deficit /
Hyperactivity Disorder and antecedents of
Borderline Personality Disorder in children
and adolescents
M. Allroggen, Universitätsklinik Ulm, Kinderund Jugendpsychiatrie (Ulm, Germany)
46
= Deutsch = English
Fri
005
A preliminary study of a group intervention
for adolescents in a child and adolescent mental health unit
P. Zaragoza, Hospital Garcia de Orta, Child &
Adolescent Psychiatry (Almada, Portugal)
I. Carvalho, I. Pereira, V. Ramos, P. Pires
012
Family therapy in female patients suffering
from borderline personality disorder and eating disorder with positive suicidal history
D. Marcinko, Clinical Hospital Center, Psychia
tric Clinic (Zagreb, Croatia)
006
Treatment of an eleven-years-old child with
elements of the dialectical behavioral therapy
for adolescents
A. Stippel, Universität Köln, Kinder und Jugendpsychiatrie (Cologne, Germany)
M. Krischer, G. Lehmkuhl
P-011
007
Identity misbalance: norm limits and youth
crisis
H. Verzhybok, Minsk State Linguistic University,
Dept. of Psychology (Minsk, Belarus)
K. Shinhel
008
Attachment and personality traits in adolescents with Borderline Personality Disorder
and their parents
V. Ramos, ISPA (Lisbon, Portugal)
I. Leal, J. Maroco, A. Mendes, G. Canta
009
Dialectical Behavior Therapy with Adolescents within the setting of the day care unit
for child and youth psychiatry, Saarland-Heilstätten GmbH Saarbrücken
A. Dixius, Saarland-Heistätten GmbH, Kinderund Jugenpsychiatrie (Saarbrücken, Germany)
E. Möhler, F. Resch
010
Theory and efficiency of dialectical behaviour
therapy in suicidal adolescents with borderline personality disorders
A. Janelle, (Greenfield Park, Canada)
R. Labelle
011
The European Research Network on Borderline Personality Disorder (EURNET BPD). Out
line and methodology of the study
A. Pham-Scottez, F. Perez-Diaz, V. Delvenne,
P. Stephan, H. Lida-Pulik, J. M. Baleyte,
D. Cohen, J. D. Guelfi, M. Corcos
Poster Session
12.30 – 13.30 h // Foyer C 02
Topic 15: Healthcare and Economics
Healthcare and Economics
Chair: D. Braakmann (Wien, Austria)
001
Voice-Hearing in Borderline Personality Disorder
S. Tschöke, ZfP Südwürttemberg, Weissenau,
Psychiatrie and Psychotherapie (Ravensburg,
Germany)
C. Uhlmann, T. Steinert
002
Psychotherapists’ attitudes towards the treatment of patients with Borderline Personality
Disorder - Two studies of outpatient care in
the city of Munich and a rural area
A. Jobst, Med. Universität München, Psychia
trische Klinik (Munich, Germany)
K. Kastouni, S. Hörz, A. Birkhofer, P. Martius,
M. Rentrop
003
Review of the role and costs of the day hospital in the treatment of the severe personality
disorders: Design and implementation of a
specific program in two day hospitals in the
City of Barcelona
M. J. Rufat, Centre de Psicoterapia, Hospital de
Dia CPB (Barcelona, Spain)
J. Barrachina Coll, E. Verdaguer, J. Barba,
L. Morales, S. Gimeno, D. Padilla, A. Moreno
004
Classification and diagnosis of borderline personality disorders
V. Semke, Mental Health Research Inst., of
Borderline States (Tomsk, Russia)
= Deutsch = English
47
Fri
005
A study of self-rated narcissism in relation to
diagnostic criteria for borderline and narcissistic personality disorders in psychiatric outpatient
I. Olssøn, Innlandet Hospital Trust, Hamar
Outpatient Clinic (Hamar, Norway)
A. A. Dahl
006
Predicting Borderline Personality Disorder diagnosis from primitive defenses in a clinical
sample
M.-H. Blais-Bergeron, École de Psychologie,
F.-A. Savard, Université Laval (Québec, Canada)
S. Sabourin, S. Bouchard, L. Normandin,
J. Clarkin, D. Lévesque
007
Narrative paths to the comprehension of the
borderline disorder in adolescents
M. Spodenkiewicz, Institut Mutualiste Montsouris,
Psychiatrie de lÁdolescent (Paris, France)
M. Jeannot, O. Taieb, M. Speranza, A. RevahLevy, M. Corcos
008
Exploration of personality factors: the externalizing mode of functioning
C. Bös, (Wien, Austria)
009
The Italian version of the Inventory of Personality Organization (IPO): Preliminary results
E. Preti, Università di Milano-Bicocca, Dept. of
A. Prunas, F. Madeddu, S. Dazzi
48
= Deutsch = English
S-014
Symposium
13.30 – 15.00 h // Hall C 01
Topic 16: Mentalization Based Therapy
Mentalization-based treatment for borderline personality disorder: A summary of the
evidence, new evidence and recent developments in different dosages and treatment
population
Chair: A. Bateman (London, United Kingdom)
Co-Chair: L. van den Bosch (Deventer, Netherlands)
001
Summary of the evidence
D. Bales, De Viersprong, VISPD (Halsteren, The
Netherlands)
M. Smits, H. Andrea
002
Matched samples: patient characteristics and
treatment outcome for Mentalization-Based
Treatment versus other psychotherapeutic
treatment settings
H. Andrea, De Viersprong, VISPD (Halsteren,
The Netherlands)
D. Bales, M. Smits
003
New developments in mentalization-based
treatment: Double diagnosed patients and future plans
M. Smits, De Viersprong, VISPD (Halsteren, The
Netherlands)
D. Bales, H. Andrea
004
Mentalization-based treatment for severe
personality disorders in adolescents
J. Hutsebaut, De Viersprong, VISPD (Halsteren,
The Netherlands)
D. Bales
Fri
S-015
Symposium
13.30 – 15.00 h // Hall B 5/6
Affective instability in borderline personality
disorder
Chair: J. Paris (Montreal, Canada)
Co-Chair: I. Daig (Berlin, Germany)
001
Assessing and understanding affective instability in Borderline Personality Disorder
J. Paris, SMBD-JGH, Dept. of Psychiatry (Montreal, Canada)
J. Russell, D. Moscowitz
002
Affective instability and suicidal ideation and
behavior in patients with BPD
P. Links, University of Toronto, Dept. of Psychiatry (Toronto, Canada)
003
Two aspects of disturbed emotional processing in borderline personality disorder
S. C. Herpertz, Universität Heidelberg, Klinik für
Allgem. Psychiatrie (Heidelberg, Germany)
G. Domes, L. Schulze
004
Sensitization and habituation of neural networks in response to aversive social cues in
borderline and avoidant personality disorder
patients
H. Koenigsberg, Mount Sinai School of Medicine,
Dept. of Psychiatry (New York, USA)
J. Fan, X. Liu, K. Ochsner, A. S. New,
M. Goodman, L. Siever
S-016
Symposium
13.30 – 15.00 h // Hall B 7/8
Memory alterations in patients with borderline personality disorder: Experimental research and clinical implications
Chair: C. Spitzer (Hamburg, Germany)
Co-Chair: S. Barnow (Heidelberg, Germany)
001
Stress, the hypothalamus-pituitary-adrenal
(HPA) axis and memory
B. Elzinga, Leiden University, Psychosomatic
Medicine (The Hague, The Netherlands)
M. Tollenaar, N. Oei
002
HPA axis and memory in borderline personality disorder
K. Wingenfeld, UKE Hamburg-Eppendorf,
Psychosomat. Medizin (Hamburg, Germany)
M. Driessen, B. Löwe, O. T. Wolf
003
Reduced Autobiographical Memory Specifi
city in Patients with Borderline Personality
Disorder and Comorbid Posttraumatic Stress
Disorder
A. Lischke, Universität Rostock, Klinik und Poliklinik für (Rostock, Germany)
S. Herpertz, H. Grabe, H. J. Freyberbger,
C. Spitzer, S. Barnow
004
Influence of emotions on working memory in
borderline patients
A. Krause-Utz, ZI für Seelische Gesundheit,
Psychosomat. Medizin (Mannheim, Germany)
C. Schmahl, N. Oei, M. Bohus, B. Elzinga
Symposium
S-017
13.30 – 15.00 h // Hall B 09
Social cognitions and emotions in the interpersonal context
Chair: B. Renneberg (Berlin, Germany)
Co-Chair: A. Arntz (Maastricht, The Nether
lands)
001
Shame and social exclusion in borderline personality disorder
B. Renneberg, Freie Universität Berlin, Inst. für
I. Wolf, K. Staebler
002
I hate myself, I like myself: Self-esteem discrepancies and severity of symptoms in patients with Borderline Personality Disorder
A. Vater, Freie Universität Berlin, Institut für
M. Schröder-Abé, A. Schütz, C.-H. Lammers,
S. Röpke
= Deutsch = English
49
Fri
003
Interpersonal evaluations in Borderline Personality Disorder: Dichotomous, affectively
polarized and negativistic assessments of
others and others‘ emotions
S. Sieswerda, Med. Universität Heidelberg,
Klinische Psychologie (Heidelberg, Germany)
A. Arntz, S. Barnow
004
Social cognition in borderline personality disorder
Symposium
S-018
13.30 – 15.00 h // Hall A 01
29. Suicidality
From parenthood to suicidality, different aspects of care possibilities in borderline personality disorder
Chair: L. Gicquel (Paris, France)
Co-Chair: K. von Auer (Lübeck, Germany)
001
Maternal borderline perosnality disorder and
parenthood
G. Apter, EPS Erasme (Antony, France)
002
A five- year follow up of patients with borderline personality disorders, the role of affective
instability , impulsivity or interpersonal problems in predicting suicide attempts
I. Secret-Bobolakis, General Hospital Psychiatry
(Lagny-sur-Marne, France)
003
Borderline personality and suicidality: An innovative trial
A. Pham-Scottez, C.M.M.E. (Paris, France)
004
Transcranial magnetic stimulation for borderline personality disorder: Rationale, stimulation site and methods
L. Cailhol, Centre Hospitalier Général, Urgences
Psychiatriques (Montauban, France)
50
= Deutsch = English
S-019
Symposium
13.30 – 15.00 h // Hall A 03
Neurobiological Aspects of Emotion, Motivation and Impulsive Behavior from Neuroimaging Studies
Co-Chair: F. Bermpohl (Berlin, Germany)
001
Molecular mechanisms of emotion, impulsivity and aggressive behaviour
B. Schott, Charité Berlin, Klinik für Psychiatrie
(Berlin, Germany)
002
Emotion and motivation in bipolar disorder
and addictive disorder
F. Bermpohl, Charité Berlin, Psychiatrie und
Psychotherapie (Berlin, Germany)
003
Ventral striatal activation during reward anticipation and impulsivity in alcohol-dependent patients
A. Beck, Charité Berlin, Psychiatrie CCM (Berlin,
Germany)
F. Schlagenhauf, T. Wüstenberg, T. Kienast,
B. Knutson, J. Wrase, A. Heinz
004
Dopamine in amygdala and the anterior cingulate cortex regulates processing of anxiety
T. Kienast, Schön Klinik Hamburg-Eilbek, Dept.
of Psychiatry (Hamburg, Germany)
F. Schlagenhauf, J. Wrase, Y. Kumakura,
P. Cumming, A. Hariri, R. Dolan, A. Heinz
S-020
Symposium
13.30 – 15.00 h // Hall A 04
Neuroimaging in adolescent borderline personality disorder
Chair: R. Brunner (Heidelberg, Germany)
Co-Chair: K. Konrad (Aachen, Germany)
001
Gender differences in brain development during puberty: a vulnerable period for the onset
of psychiatric disorders
K. Konrad, University Hospital of the RWT
(Aachen, Germany)
Fri
002
Structural neuroimaging early in the course
of borderline personality disorder
A. Chanen, University of Melbourne, Centre for
Youth Mental Health (Melbourne, Australia)
003
A voxel-based morphometric study of female
adolescents with borderline personality dis
order: are reductions in frontal gray matter
disorder-specific?
R. Henze, Med. Universität Heidelberg, Kinderund Jugendpsychiatrie (Heidelberg, Germany)
004
Microstructural abnormalities of the fornix in
female adolescents with borderline personality disorder: A diffusion tensor imaging study
R. Brunner, Med. Universität Heidelberg, Kinderund Jugendpsychiatrie (Heidelberg, Germany)
S-021
Symposium
13.30 – 15.00 h // Hall A 05
Basic mechanisms of aversive learning in
BPD
Chair: O. Tüscher (Freiburg, Germany)
001
Evidence of White Matter Disruption Related
to Brain Regions Underlying Emotion Recognition in Adolescents with BPD
D. Carpenter, J. Avedon, M. Goodman
002
Physiological differences in startle habituation in women with borderline personality
disorder
C. Scheel, Universität Freiburg, Psychologische
Fakultät (Freiburg, Germany)
O. Tuescher, B. Feige, U. Ebner-Priemer,
N. Rüsch, K. Lieb, G. Jacob
003
Influence of dissociation on information pro
cessing in stress-related disorder
J. Mauchnik, ZI für Seelische Gesundheit
(Mannheim, Germany)
U. Ebner-Priemer, C. Schmahl, M. Bohus
004
Instructed fear learning in BPD
S. Kamphausen, G. Jacob, K. Lieb
Symposium
S-022
13.30 – 15.00 h // Hall A 06
Emotion regulation in BPD: Assessment, psychopathology and treatment
Chair: U. Ebner-Priemer (Karlsruhe, Germany)
Co-Chair: T. Trull (Columbia, USA)
001
Correlates of affective instability in BPD
T. Trull, University of Missouri (Columbia, USA)
002
SMS-feedback to support emotion regulation
in BPD
L. Mussgay, (Bad Kreuznach, Germany)
S. Solzbacher, M. Memmesheimer, H. Rüddel
003
Affective instability in BPD, PTSD and Eating
Disorder
U. Ebner-Priemer, Karlsruher Institute für
Technologie (Karlsruhe, Germany)
T. Prill, I. Reinhard, M. Bohus, R. Steil
004
Does Dysfunctional Behavior Improve Affect
and Distress in Everyday Life?
P. Santangelo, Karlsruher Institute für Technolo
gie (Karlsruhe, Germany)
U. Ebner-Priemer, S. Koudela
Symposium
S-023
13.30 – 15.00 h // Room B 03
Dialectical Behavior Therapy (DBT) training
in Europe: Sharing the experience
Chair: C. Maffei (Milan, Italy)
Co-Chair: S. Manning (Seattle, USA)
001
DBT Training in the European Community
S. Manning, Behavioral Tech., LLC (Seattle,
USA)
= Deutsch = English
51
Fri
002
Disseminating DBT: Comparative rates of dissemination in the US, UK and Germany
M. Swales, Bangor University, School of
Psychology (Gwynedd LL57 2AS, United
Kingdom)
003
The Italian DBT Training Project (IDTP): an
ongoing experience
L. Barone, University, Psychology Department
(Pavia, Italy)
C. Maffei
Special Session
SP-002
15.15 – 16.45 h // Hall B 5/6
DSM-V Working Group – Round Table Debate
Chair: J. Oldham (Houston, USA)
Practice Seminar
PS-122
15.15 – 18.15 h // Hall B 7/8
Transference-Focused Psychotherapy for Bor
derline Patients
J. Clarkin (White Plains, USA)
P. Buchheim (Munich, Germany)
Practice Seminar
PS-123
15.15 – 18.15 h // Hall A 03
Einführung in die Dialektisch Behaviorale
Therapie bei Patienten mit Borderline-Per
sönlichkeitsstörung und komorbidem Substanzmissbrauch oder -abhängigkeit (DBTS)
S. Reiske (Berlin, Germany)
B. Kraus (Berlin, Germany)
T. Kienast (Hamburg, Germany)
Practice Seminar
PS-124
15.15 – 18.15 h // Hall A 04
DBT-A in der stationären Kinder- und Jugend
psychiatrie
K. von Auer (Lübeck, Germany)
S. Ludewig (Lübeck, Germany)
52
= Deutsch = English
PS-125
Practice Seminar
15.15 – 18.15 h // Hall A 05
Grundlagen, Behandlungsmethoden und -instrumente der Dialektisch-Behavioralen-The
rapie (DBT) im Rahmen eines stationären
Therapiekonzeptes
H. Barthruff (Freiburg, Germany)
PS-126
Practice Seminar
15.15 – 18.15 h // Hall A 06
Topic 23: PTSD
Dialektisch-Behaviorale Therapie der Posttraumatischen Belastungsstörung nach sexu
alisierter Gewalt in der Kindheit – eine neue
Behandlung
R. Steil (Frankfurt, Germany)
A. Dyer (Mannheim, Germany)
PS-127
Practice Seminar
15.15 – 18.15 h // Room B 03
Topic 10: Eating Disorders
DBT-Eating Disorders
U. Schweiger (Lübeck, Germany)
PS-128
Practice Seminar
15.15 – 18.15 h // Hall B 09
DBT Mindfulness Radical Acceptance and
Willingness
M. Linehan (Washington, USA)
PS-129
Practice Seminar
15.15 – 18.15 h // Hall A 01
Topic 13: Family
BPD Psychoeducation: Collaborating for
Change Family Members as Clinical Allies
V. Porr (New York, USA)
G. Feinberg
R. Piscitelli
S. Piscitelli
Fri
OP-010
Oral Presentation
15.15 – 16.45 h // Hall C 01
Treatment Development and Training
Chair: A. Arntz (Maastricht, The Netherlands)
Co-Chair: L. van den Bosch (Deventer, The
Netherlands)
001
New online solutions for the training and education for staff working in forensic and nonforensic settings with individuals with borderline and antisocial personality disorders
E. Kane, Institute of Mental Health, Duncan Macmillan House (Nottingham, United Kingdom)
N. Gordon, V. Baldwin
002
Dialectical Behavior Therapy with Adolescents (DBT-A):Predictors for successful the
rapy and comorbidity by adolescents with
symptoms of borderline-personality disorder
S. Eisenbeis, SHG-Klinik, Kinder- und Jugend
psychiatrie (Kleinblittersdorf, Germany)
E. Möhler
003
Using dialectical behaviour therapy principles
in secondary consultations for staff teams not
specifically trained in treatment for Borderline Personality Disorder
A. Banfai, Melbourne Health, Northern AMHS
(Preston, Australia)
004
An internet based discussion board for persons with borderline personality disorders
moderated by health care professionals
V. Habermeyer, Universitätsklinik Zürich, Abt.
Psychiatrie (Zürich, Switzerland)
E. Habermeyer
005
Emotion Regulation Patterns of Patients with
Different Psychiatric Disorders
K. Endtner, UPD Bern, Abt. für Psychotherapie
(Bern, Switzerland)
M. Hänni, W. Tschacher
006
A programme for the social psychiatric management of ‚difficult to treat‘ borderline patients
A. Kaasenbrood, Pro Persona, ACT-Team
Arnhem (Arnhem, The Netherlands)
J. Fiselier
Oral Presentation
OP-011
16.45 – 18.15 h // Hall C 01
Psychopathology
Chair: T. Lynch (Exeter, United Kingdom)
Co-Chair: B. Renneberg (Berlin, Germany)
001
Variability of maladaptive assumptions in
D. Spretz, (Berlin, Germany)
E. Strauß, J. Stecher-Mohr, B. Renneberg,
C. Stiglmayr
002
Attachment disorganization in Borderline
Personality Disorder assessed with two independent interview measures
A. Buchheim, Med. Universität Innsbruck, Psychosomat. Zahnheilkunde (Innsbruck, Austria)
S. Hörz, M. Fischer-Kern, S. Doering
003
Borderline personality disorder and other
personality disorders: associations with temperament and character traits, early maladaptive schemas and psychopathological symptoms
Z. Unoka, Semmelweis University (Budapest,
Hungary)
D. Fogd, P. Czobor
004
Shame-proneness in attempted suicide women with borderline personality disorder
M. Wiklander, Karolinska Institutet, Dept. of
Clinical (Stockholm, Sweden)
J. Jokinen, G. Rylander, B. Nyström, Å. Nilsonne,
A. Wilczek, M. Samuelsson, M. Åsberg
005
Implicit and explicit self-esteem in borderline
M. Marissen, PsyQ, Dept. Personality Disorders
(The Hague, The Netherlands)
= Deutsch = English
53
Fri
006
Associations between Borderline Personality
Disorder features and mate retention tactics
S. Tragesser, Washington State University, Dept.
of Psychology (Richland, USA)
J. A. Benfield
Oral Presentation
OP-012
16.45 – 18.15 h // Hall B 5/6
Neurobiology
Co-Chair: L. Siever (New York, USA)
001
Simulating the Borderline Personality Disorder brain
C. Berdahl, American Airlines (Reston, USA)
002
Empathy and Social Cognition in Borderline
and Narcissistic Personality Disorder: Behavioral and fMRI Data
S. Röpke, Charité Universitätsmedizin, Inst. für
I. Dziobek, S. Preißler, K. Ritter, H. Heekeren
003
Impaired decision-making and feedback evaluation in borderline personality disorder
B. Schürmann, Humboldt-Universität zu Berlin,
Inst. für Klin. Psychologie (Berlin, Germany)
N. Kathmann, C. Stiglmayr, B. Renneberg,
T. Endrass
004
Structural changes of the temporolimbic
system and associations between amygdala
volume, depression and a functional serotonin
1A receptor gene polymorphism in borderline
T. Zetzsche, Ludwig-Maximilian University
(Munich, Germany)
U. Preuss, B. Bondy, H.-J. Moeller, E. Meisen
zahl
005
ERP-abnormalities in borderline personality
disorder: Error related negativity and sensory
motor gating
K. Grootens, CWZ General Hospital, Dept. of
Psychiatry (Nijmegen, The Netherlands)
54
= Deutsch = English
006
Alexithymia in Borderline Personality Disorder: Clinical and neurophysiological findings
S. Lang, Universität Heidelberg, Inst. für
Psychologie (Heidelberg, Germany)
M. Stopsack, H. Grabe, C. Spitzer, S. Barnow
S-024
Symposium
18.30 – 20.00 h // Hall C 01
Findings from a Canadian randomized trial
comparing dialectical behaviour therapy to
general psychiatric management: Predictors
of drop-out, risk factors for suicide and patterns of health care utility
Chair: S. McMain (Toronto, Canada)
Co-Chair: L. Dimeff (Seattle, USA)
001
Predictors of treatment drop-out in two treatments for borderline personality disorder
S. McMain, CAMH and University of Toronto
(Toronto, Canada)
P. Links, T. Guimond, S. Wnuk
002
Prospective risk factors for suicide attempts
in a treated sample of patients with Borderline Personality Disorder (BPD)
P. Links, University of Toronto, Dept. of
Psychiatry (Toronto, Canada)
N. Kolla, S. McMain, T. Guimond
003
Health care utilization patterns and associated costs amongst patients with Borderline
Personality Disorder (BPD) treated with Dialectical Behaviour Therapy (DBT) versus General Psychiatric Management (GPM)
T. Guimond, CAMH, Dept. of Psychiatry
(Toronto, Canada)
C. Dewa, W. Gnam, E. Lin, S. McMain
Fri
S-025
Symposium
18.30 – 20.00 h // Hall B 5/6
Outpatient DBT-treatment systems in Europe
Chair: C. Stiglmayr (Berlin, Germany)
Co-Chair: H. Gunia (Darmstadt, Germany)
001
Outpatient DBT treatment in the United Kingdom
B. Baragwanath, (United Kingdom)
002
DBT outpatient treatment of substance abusing, forensic and ‘normal’ BPD patients in the
Netherlands
L. van den Bosch, Dialexis, Dept. of Psychology
(Deventer, The Netherlands)
003
Two examples of very well functioning DBTprograms in Sweden
E. Malmquist, Psykologem AB (Forsheda, Sweden)
004
Presentation of the DBT-Therapy Centre in
Barcelona
B. Lopez Villar, TLP-Tratamientos (Barcelona,
Spain)
D. Molina López, M. Lavilla
005
The Berlin and Darmstadt Borderline-Networks
H. Gunia, Psychologische Praxis (Darmstadt,
Germany)
C. Stiglmayr
S-026
Symposium
18.30 – 20.00 h // Hall B 09
Dialectical behavior therapy for substance
abuse in individuals with borderline personality disorder: Results from a multi-centre
randomized controlled trial
Chair: T. Lynch (Exeter, United Kingdom)
Co-Chair: M. Bohus (Mannheim, Germany)
002
Preliminary Outcomes of a Randomized Controlled Trial of DBT versus Drug Counseling
for Opiate Dependent BPD Men and Women
003
Skills or Therapeutic Alliance? Mediators of
Mental Health & Drug Abstinence Outcomes
B. Whalley, University of Plymouth, Dept. of
Psychology (Plymouth, United Kingdom)
Symposium
S-027
18.30 – 20.00 h // Hall A 03
Integrating emotional regulation and psychobiological findings in BPD
Chair: J. L. Carrasco (Madrid, Spain)
Co-Chair: V. Perez Sola (Barcelona, Spain)
001
Cognitive reflective function and fronto-limbic disconnection
J. Clarkin, Weill Cornell Medical College, Dept. of
Psychiatry (White Plains, USA)
002
Microstructural brain damage and neurocognitive functioning in BPD
J. L. Carrasco, Complutense University,
Psychiatr. Hospital San Carlos (Madrid, Spain)
003
Abnormalities of stress-response mechanisms
and general cognitive-affective instability in
BPD
M. Díaz-Marsá, San Carlos University Hospital
(Madrid, Spain)
004
Cognitive-affective regulation dysfunctions
associated with speciffic emotional stimulation
J. Soler, Sant Pau Hospital, Personality Disorders
Unit (Barcelona, Spain)
J. C. Pascual
001
Randomized Controlled Trial of DBT versus
Drug Counseling for Opiate Dependent BPD
Men and Women: Methods & Implementation
T. Lynch, University of Exeter, Dept. of
Psychology (Exeter, United Kingdom)
= Deutsch = English
55
Fri
Practice Seminar
PS-130
18.30 – 20.00 h // Hall A 05
The use of imagery in a schema group therapy
M. van Vreeswijk (Delft, The Netherlands)
Practice Seminar
PS-131
18.30 – 20.00 h // Hall A 06
DBT in komplementären Arbeitsfeldern der
Sozialpsychiatrie – Chancen, Grenzen und
Konsequenzen in Theorie und Praxis
L. Meier (Kropp, Germany)
B. Wohl (Berlin, Germany)
Practice Seminar
PS-132
18.30 – 20.00 h // Room B 03
Körpertherapie in der DBT
T. Welke (Freiburg, Germany)
I. Brokuslaus (Freiburg, Germany)
PS-132 A
Practice Seminar
18.30 – 20.00 h // Hall A 04
Dialectical Behavior Therapy with Parents and
Partners to Augment Individual Outcomes
A. Fruzzetti (Reno, USA)
Oral Presentation
OP-013
18.30 – 20.00 h // Hall B 7/8
Topic 23: PTSD
PTSD
Chair: M. Berger (Freiburg, Germany)
Co-Chair: R. Steil (Frankfurt, Germany)
001
Body image disturbances in dependence of
childhood sexual abuse and scars
A. Dyer, ZI für Seelische Gesundheit, Psychoso
matische Medizin (Mannheim, Germany)
E. Borgmann, N. Kleindienst, C. Schmahl,
M. Bohus
56
= Deutsch = English
002
Dissociation, tension and the urge to selfharm in patients with borderline personality
disorder
A. Rauch, (Berlin, Germany)
D. Spretz, E. Strauß, B. Renneberg, C. Stiglmayr
003
Safety issues in exposure-based therapy in
patients with emotional instability and PTSD
after CSA
A. Krüger, ZI für Seelische Gesundheit, Klinik für
R. Steil, A. Dyer, K. Priebe, M. Bohus
004
Do retrospective questionnaires underestimate the frequency of trauma-related intrusions?
J. Zimmer, ZI für Seelische Gesundheit
(Mannheim, Germany)
K. Priebe, N. Kleindienst, U. Ebner-Priemer,
M. Bohus
005
Prevalence of borderline, post traumatic
stress disorder, experiences with sexual abuse
and rape in a large population of sadomasochists
E. Wawrzyniak, (Bottrop, Germany)
006
Treatment of patients with Borderline Personality Disorder (BPS) and Post Traumatic Stress
Disorder (PTSD) via Narrative Exposure The
rapy (NET)
J. Aldenhoff, ZIP gGmbH, Inst. für Psychiatrie
(Kiel, Germany)
K. Bernhardt, K. Gerok-Falke, A. Pabst,
M. Seeck-Hirschner, R. Göder
Fri
OP-014
Oral Presentation
18.30 – 20.00 h // Hall A 01
Topic 20: Pharmacology
Pharmacology
Chair: S. C. Herpertz (Heidelberg, Germany)
Co-Chair: K. Lieb (Mainz, Germany)
001
Reconsidering the APA guidelines for the
pharmacologic treatment of Borderline Personality Disorder
K. Silk, University of Michigan, Dept. of
Psychiatry (Ann Arbor, USA)
L. Feurino, III
003
Naltrexone as a Potential Anti-Dissociative
Agent in Borderline Personality Disorder
C. Schmahl, M. Bohus
004
Emotional Imagery In Borderline Personality
Disorder: Defensive Responses Are Cue Specific And Modulated By Co-Morbid Post-Traumatic Stress Disorder
A. O. Hamm, University of Greifswald (Greifs
wald, Germany)
S. Barnow, H. J. Freyberger
002
Evidence-Based Pharmacological Treatment
of BPD: A Neurobiological Perspective
R. Friedel, Virginia Commonwealth, University
(Midlothian, USA)
Congress Dinner
The Congress Dinner will take place on Friday, 02 July 2010 in the famous Restaurant Nolle.
All attendees are invited. Join the Dinner with buffet and beverages and entertainment by the
Singing Shrinks. The social evening will start at 20.30 h.
GPrice per person: EUR 48
GRestaurant Nolle
Georgenstraße / S-Bahnbogen 203
10117 Berlin
S-Bahn-Station: Friedrichstraße
= Deutsch = English
57
Sat
Symposium
S-028
09.00 – 10.30 h // Hall C 01
New developments in schema therapy for
Chair: A. Arntz (Maastricht, The Netherlands)
001
Group schema therapy: A catalyst for recovery from BPD
J. Farrell, Indiana University, Larue Carter
Hospital (Indianapolis, USA)
002
Implementation of outpatient schema therapy
for Borderline Personality Disorder with versus without crisis support by the therapist
outside office hours: A randomized trial
M. Nadort, VU University Medical Center
(Amsterdam, The Netherlands)
003
Intensive schema therapy for patients with
N. Reiss, Universitätsmedizin Mainz, Psychiatrie
und Psychotherapie (Mainz, Germany)
K. Lieb
004
Schema therapy for Borderline Personality
Disorder: New developments in combining
individual and group schema therapy
Symposium
S-029
09.00 – 10.30 h // Hall B 5/6
New approaches to identity disturbance:
Self-esteem and self-concept in borderline
personality disorder and their relevance to
psychotherapy
Chair: M. Schröder-Abé (Chemnitz, Germany)
Co-Chair: S. Röpke (Berlin, Germany)
001
Hating oneself deep inside: Implicit self-esteem
in patients with borderline personality disorder
M. Schröder-Abé, Techn. Universität Chemnitz,
Inst. für Psychologie (Chemnitz, Germany)
A. Vater, S. Roepke, A. Schütz
58
= Deutsch = English
002
Dialectic behavioural therapy has an impact
on self-concept clarity and facets of self-
esteem in women with borderline personality
disorder
S. Röpke, Charité Universitätsmedizin, Inst. für
003
Reconceptualizing the “split self”: Self-concept structure of patients with borderline personality disorder
A. Vater, Freie Universität Berlin, Inst. für
M. Schröder-Abé, S. Weissgerber, S. Röpke,
C.-H. Lammers, A. Schütz
004
Relevance of self-esteem to the body image of
Borderline patients
E. Borgmann, ZI für Seelische Gesundheit, PSM
(Mannheim, Germany)
M. Bohus, E. Reinelt, R. Weiß, A. Dyer
S-030
Symposium
09.00–- 10.30 h // Hall A 01
Topic 20: Pharmacology
Pharmacotherapy in Borderline Personality
Disorder: Metaanalyses and latest developments
Chair: K. Lieb (Mainz, Germany)
Co-Chair: P. Links (Toronto, Canada)
001
Current evidence of efficacy of pharmacotherapy for Borderline Personality Disorder: A
metaanalysis of randomized controlled trials
J. Stoffers, University Medical Center, Depart
ment of Psychiatry and (Mainz, Germany)
B. A. Völlm, K. Lieb, G. Rücker, A. Timmer
002
Psychotropic medication during DBT versus
General Psychiatric Management according
to APA guidelines
P. Links, University of Toronto, Dept. of Psychiatry (Toronto, Canada)
S. McMain
Sat
003
The effect of quetiapine on psychotic-like
symptoms and general psychopathology in
patients with Borderline Personality Disorder:
A randomised placebo-controlled trial
R. J. Verkes, Radboud University Nijmegen
(Nijmegen, The Netherlands)
P. J. A. van den Broek, B. J. M. Penterman,
K. Grootens, J. K. Buitelaar, K. W. Hummelen
PS-133
004
New approaches in Borderline Personality
Disorder (BPD) pharmacotherapy
S. Bellino, University of Turin, Unit of Psychiatry 1
(Turin, Italy)
09.00 – 10.30 h // Hall A 04
Healing insecure attachment representations
and managing emotions
A. van Dijke (Poortgaal, The Netherlands)
S-031
Symposium
09.00 – 10.30 h // Room B 95
Topic 25: Selfharm and Pain
Interaction of disturbed pain processing and
self-injurious behavior
Co-Chair: D. Devine (Gainesville, USA)
001
The role of stress-responsiveness in self-injurious behaviors: Biochemical studies in an
animal model
D. Devine, University of Florida, Psychosomatic
Medicine (Gainesville, USA)
002
Pain sensitivity and self-injurious behavior in
BPD
P. Ludäscher, ZI für Seelische Gesundheit, Abt.
C. Schmahl
003
Barriers to Self-harm: The importance of pain
B. Turner, Simon Fraer University, Psychosomatic Medicine (Burnaby, Canada)
A. Chapman
004
Incision-induced pain in BPD
S. Reitz, ZI für Seelische Gesundheit, Psychoso
matische Medizin (Mannheim, Germany)
C. Schmahl, M. Bohus
Practice Seminar
09.00 – 10.30 h // Hall A 03
Psychoeducation for patients with Borderline Personality Disorder (BPD)
M. Rentrop (Munich, Germany)
Practice Seminar
PS-134
Practice Seminar
PS-135
09.00 – 10.30 h // Hall A 05
Modified dialectical behavior therapy for individuals with intellectual disabilities
B. F. Barrett (Berlin, Germany)
Practice Seminar
PS-136
09.00 – 10.30 h // Hall A 06
Einführung in Stepps
U. Herrmann (Warstein, Germany)
E. Rahn (Warstein, Germany)
Practice Seminar
PS-137
09.00 – 10.30 h // Room B 03
Struktur und Inhalte für die Pflege der Dialek
tisch-behavioralen Therapie der Essstörung
D. Greßing (Lübeck, Germany)
S. Berg (Lübeck, Germany)
Practice Seminar
PS-138
09.00 – 10.30 h // Hall B 09
Clinical subgroups of patients with borderline personality disorder: Description, assess
ment and specific intervention strategies
M. Walter (Basel, Switzerland)
E. Ronningstam (Belmont, USA)
S. Hörz, LMU München, Department Psycholo
gie (Munich, Germany)
I. Weinberg, McLean Hospital, (Belmont, USA)
= Deutsch = English
59
Sat
RT-001
Round-Table
09.00 – 10.30 h // Hall B 7/8
Betroffenen-Diskussionsforum: Ich sehe was, was Du nicht siehst …
Borderline-Erfahrungswissen bedeutsam für Therapie, Supervision und Forschung?
Chair: H. Gunia (Darmstadt, Germany)
Discussant: M. Bohus, ZI für Seelische Gesundheit, Inst. für Psychosomatik, Mannheim (Mannheim,
Germany)
C. Tilly, LWL Klinik Warstein (Warstein, Germany)
T. Schenkel, Grenzposten e. V., Rostock (Rostock, Germany)
A. Link, BorderlineTrialog, Informations- und Kontaktstelle, Nürnberg (Nürnberg, Germany)
H. Gunia, Psychologische Praxis, Darmstadt (Darmstadt, Germany)
S. Asbrand, Borderline-Netzwerk e. V., Kiel (Kiel, Germany)
B. Düformantel, Hamburg (Hamburg, Germany)
Die Zusammenarbeit von Professionellen und Betroffenenverbänden wird in der Behandlung psychischer Erkrankungen als immer wichtiger erachtet. Insbesondere vom Dachverband DBT wird
diese Zusammenarbeit sehr gepflegt und geschätzt. In dieser Diskussionsrunde, in der Repräsentantinnen von drei Borderline-Betroffenenverbänden in Deutschland vertreten sind, soll es um die
Frage gehen, ob sich Betroffene noch stärker als bisher üblich in Therapie, Supervision, Forschung
und Ausbildung beteiligen können und auch sollen. Diesbezüglich werden die Betroffenen kurze
Statements abgeben und hinterher mit den anwesenden Professionellen diskutieren.
Plenary Session
PL-005
11.00 – 11.45 h // Hall C 01
Mentalization Based Therapy – State of the
Art
Peter Fonagy, UCL Psychoanalysis Unit, Research
Dept of Clinical, (London, United Kingdom)
Moderation: Sabine C. Herpertz (Heidelberg,
Germany)
PL-006
Plenary Session
11.45 – 12.30 h // Hall C 01
Dialectical Behavior Therapy (DBT): Where
Are We Now?
Marsha Linehan, University of Washington,
Dept. of Psychology (Washington, USA)
Moderation: Thorsten Kienast (Hamburg,
Germany)
Special Session
SP-003
12.30 – 13.00 h // Hall C 01
Closing and Award Ceremony
Chair: M. Bohus (Mannheim, Germany) // Co-Chair: T. Rinne (Utrecht, The Netherlands)
Awards:GESSPD – Outstanding Research Awards 1st International Congress on Borderline
Personality Disorder 2010, Berlin
GGerman DBT Association Poster Awards
GTARA Award 2010
60
= Deutsch = English
Acknowledgements
The organisers of the 1st International Congress on Borderline Personality Disorder gratefully
acknowledge the support of the following companies:
Sponsors
List of exhibitors
G Bristol-Myers Squibb GmbH & Co. KGaA
G Bristol-Myers Squibb GmbH & Co. KGaA
G Pfizer GmbH
G Schön Klinik Hamburg Eilbek
G Otsuka
G Psychiatrie-Verlag
G Pfizer GmbH
G Psychosozial-Verlag
G Schattauer Verlag
G Schattauer GmbH
G Schön Klinik Hamburg Eilbek
G GRENZPOSTen e. V.
G Rhein-Jura Klinik, Bad Säckingen
61
Congress Information
Registration Fees
On-site registration will be processed on a first-come, first-served basis. Priority will be given to
pre-registered delegates.
EUR
Member DBT-Network
180,00
Non-Member 350,00
Affiliated health care professionals (Nursing Staff)*
190,00
Students*
90,00
Practice Seminars, 1,5 h**
50,00
Practice Seminars, 3 h**
80,00
Congress Dinner, 2 July 2010
48,00
* A certificate must be handed in together with the registration.
** Only in combination with the congress fee.
The registration fee for participants includes:
GAdmission to all scientific sessions
GAdmission to Opening Ceremony and Get Together on Thursday, 01 July 2010
GAdmission to poster exhibition and technical exhibition
GFinal programme
A certificate of attendance will be handed out upon demand at the registration counter.
Congress Registration Counter
All conference material are available at the re
gistration counter located in the entrance foyer B
of the bcc.
Opening hours
Thu, 01 July 2010 Fri, 02 July 2010 Sat, 03 July 08.00 – 19.00 h
08.00 – 19.00 h
08.00 – 13.00 h
During these opening hours the congress counter can be reached at:
Phone: +49 – 30 – 23 80 68 81
Fax: +49 – 30 – 23 80 68 85
Congress Programme and Abstracts
The final congress programme will be issued to
all registered attendees at the congress in the
bcc and is also available at the congress’ website. All accepted abstracts are published online
at www.borderline-congress.org
Congress Programme Changes
The organisers cannot assume liability for any
changes in the congress programme due to external or unforeseen circumstances.
62
Media and Internet Centre
The Media and Internet Centre is located in A 08
on level A of the bcc. Speakers are asked to
hand in their CD-ROM or USB stick containing
the PowerPoint presentation (IBM format or com
patible, no multisession) preferably 3 hours before their presentation, but at the latest 1 hour
prior to the presentation. The presentation will
be transferred to the central congress server
and will be available afterwards on a special
congress notebook in the hall of the presentation. Due to time and technical reasons we kindly ask the speakers not to use their own notebook. Technical staff will be happy to assist you.
Internet will be available for free.
Opening hours
Thu, 01 July 2010 Fri, 02 July 2010 Sat, 03 July 2010 08.00 – 19.00 h
08.00 – 18.30 h
08.00 – 11.00 h
CME Accreditation
The 1st International Congress on Borderline
Personality Disorder is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide CME ac
tivity for medical specialists. The EACCME is an
institution of the European Union of Medical
Specialists (UEMS), www.uems.net.
The 1st International Congress on Borderline Per
sonality Disorder is designated for a maximum
of 15 CME credit points of European external
CME credits. Each medical specialist should
claim only those hours of credit that he / she
actually spent in the educational activity.
EACCME credits are recognized by the Ameri
can Medical Association towards the Physcian’s
Recognition Award (PRA). To convert EACCME
credit to AMA PRA category 1 credit, contact
the AMA.
The Ärztekammer Berlin has granted 15 points to
the congress. The following points are given for
each congress day:
01 July G 6 points per full congress day and
3 points per half day
02 July G 6 points per full congress day and
3 points per half day
03 July G 3 points per half day
The following points are given for the Practice
Seminars:
Per Practice Seminar (90 min) G 3 points
Per Practice Seminar (180 min) G 5 points
Participants interested in obtaining EACCME
credits and CME points of the Ärztekammer Ber
lin (please provide your barcode) may contact
the staff at the registration counter on the last
day of attendance in order to receive a printed
copy of their accreditation certificate.
Name Badges
Participants are kindly requested to wear their
name badge at all times during the conference
including the Opening Ceremony and Get Together.
Poster Exhibition
The poster exhibition is located in the foyer on
level C of the bcc. The posters will be sorted by
topics and will be numbered within those topics. The poster exhibition is open to all registered delegates.
Set-up and dismantling times for posters
Posters need to be set up and dismantled within
the following times:
G Set-up:
Thu, 01 July 2010 09.00 – 12.00 h
G Dismantling:
Sat, 03 July 2010 10.30 – 12.30 h
Posters which have not been removed within
the indicated dismantling time will be disposed.
There will be 11 poster sessions during the congress. The posters will be grouped into thematic
Guided Poster Tours chaired by renowned specialists. The Guided Poster Tours will give the
authors the opportunity to present their findings
and discuss them with the audience. The best
posters will be awarded.
Technical Exhibition
The 1st International Congress on Borderline
Personality Disorder will be accompanied by a
technical exhibition in the foyer on level B of the
bcc.
The exhibition will be open from
Thu, 01 July 2010 09.00 – 17.00 h
Fri, 02 July 2010 09.00 – 17.00 h
Sat, 03 July 2010 09.00 – 12.30 h
Congress Dinner
The Congress Dinner will take place on Friday,
02 July 2010 in the famous Restaurant Nolle.
All attendees are invited. Join the Dinner with
Buffet and Drinks and entertainment by the
Singing Shrinks. The social evening will start
from 20.30 h
GPrice per person: EUR 48
GRestaurant Nolle
Georgenstraße / S-Bahnbogen 203
10117 Berlin
S-Bahn-Station: Friedrichstraße
63
Car Park
Plenty of parking space is available on the parking deck of the ALEXA shopping mall.
Cash Machine
An ATM / cash machine is located in the ALEXA
shopping mall or opposite of the BCC.
Public Transportation
The bcc is directly located at the underground
station Alexanderplatz.
Underground: U2, U5, U8
S-Bahn: S5, S7, S75, S9
Bus: TXL (Airport), 100, 200, 248, N5, N65, N8
Metro: M4, M5, M6, M48, N92
Taxi: Airport Tegel and Airport Schönefeld
(about 45 Minutes)
Taxis
Taxis are available at the entrance of the bcc or
can be reached at:
G +49 – (0)30 – 210 202
G +49 – (0)30 – 261 026
Congress Venue
bcc Berliner Congress Center
Alexanderstr. 11, 10178 Berlin, Germany
S-Bahn and Underground station:
Alexanderplatz
Restaurant
Nolle
64
Get Together
All participants are invited to the Get Together
of the 1st International Congress on Borderline
Personality Disorder on Thursday 01 July, 2010
at 20.00 h in the foyers at the bcc. Snacks and
drinks will be served.
Press
The press centre is located in room B 96 on level
B in the bcc.
Simultaneous Translation
All sessions marked with
will be translated
simulaneously from English into German and
vice-versa.
W-LAN
In order to log on to the available W-LAN network at the bcc, please find the network named
“Borderline” and connect without a password.
The City of Berlin
The new Berlin presents itself to visitors as a
cosmopolitan city. The Brandenburg Gate, once
a symbol of the divided Germany, has become
the emblem of the German capital. Nearly all
traces of the wall which divided Berlin for almost 30 years have now disappeared. Today,
Berlin is situated in the heart of a continent
moving towards unification, and plays an important role in the European integration pro
cess. Because of its geographical position and
its favourable transport routes making it the
gateway to Central and Eastern Europe, Berlin
has a stimulating influence on the enlargement
of the European Union to the east.
In an area of about 891 km², Berlin unites a
large number of urban districts, which are completely different in character. Of the 3.4 million
inhabitants of Berlin, more than 434,000 people
are not of German origin. They come from more
than 180 different nations and provide Berlin
with a large variety of lifestyles and cultures.
Berlin is one of the prime locations for science
or research facilities and the media. The private
service sector has become the motor of the
city‘s economy. As a Competence Centre, Berlin
has relied on the fields of technology, biotechnology, medical and environmental technology.
Globally operating firms draw benefit from the
large number of institutions resident in Berlin
and the knowledge available here. Furthermore,
with about 140,000 students and about 40,000
people working at universities, Berlin is Germany‘s largest university city.
Berlin‘s cultural scene offers unlimited opportu
nities for leisure activities: three opera houses,
four large musical theaters, over 150 theaters
and numerous cabaret-theaters, 170 museums
and collections as well as 300 art galleries and
130 cinemas. The Museumsinsel (Museum Island)
with its world-famous museums was inscribed
on UNESCO‘s World Heritage list in 1999. Furthermore, a large number of fairs, exhibitions and
congresses attract visitors. Especially the Kur
fürstendamm, Friedrichstrasse and Potsdamer
Platz are ideal places for extensive shopping trips.
And one should not forget the countless cafés,
pubs and restaurants having both local and international specialties ready for their guests.
But Berlin is also a green city. Numerous woods,
lakes, parks and gardens offer recreation for
everyone. In addition, the historical city of Potsdam in the neighbouring Land of Brandenburg,
with its historic palaces and gardens and numerous highlights of historical and modern municipal architecture, invites visitors to stay for a
while.
65
Index of Chair Persons and Authors
A
Aarela, E.
39
Aarnio, J.
29
Abadie, P.
42
Ahlers, C. J.
41
Aldenhoff, J.
56
Alff-Petersen, S.
43
Allard, N.
44
Allen, J. S.
37
Allroggen, M.
46
Alm, B.
38
Álvarez, E.
44
Alvarez Tomas, I.
44
Amengual, J.
31
Amin, S.
45
Andersen, D.
30
Andión-Pérez, Ó.
29, 30,
31, 35, 44
Andrea, H.
34, 40, 48
Andreoli, A.
40
Andresen, B.
30
Anker, S.
46
Apfalter, I.
46
Apter, G.
50
Ardelan, M.
35
Arens, E.
36
Arntz, A.
33, 34, 37,
49, 50, 53, 58
Asano, M.
45
Åsberg, M.
53
Asbrand, S.
60
Astrid, P.
30
Auer, K. von
36, 50, 52
Avedon, J.
51
Avgustin Avcin, B.
45
B
Bader, K.
26, 38
Bagby, R. M.
34
Bahri, S.
41
Baiget, M.
31
Balanzin, D.
35
Baldwin, V.
53
Bales, D.
48
Balestrieri, M.
31
Baleyte, J. M.
47
Banfai, A.
53
Baragwanath, B.
55
Barba, J.
47
Barbini, D.
44
Barker, D. P. J.
29
Barnicot, K.
39, 40, 44
Barnow, S.
36, 49, 50, 54, 57
Barone, L.
52
Barrachina Coll, J.
29
Barral Picado, C.
30, 44
Barrett, B. F.
59
Bartak, A.
40
Barthruff, H.
52
Basogianni, V.
45
Bastiaansen, L.
29
66
Bateman, A.
26, 48
Bayer, K. M.
44
Beatson, J.
39
Beblo, T.
31, 43
Beburishvili, A.
30
Beck, A.
50
Behm, R.
38
Bellino, S.
59
Bell, R.
27
Bell, T.
32
Beltri, R. Torrubia
31
Benfield, J. A.
54
Berdahl, C.
54
Berger, C.
31
Berger, M.
56
Berg, S.
59
Bermpohl, F.
50
Bernhardt, K.
56
Bertelli, G.
44
Berthoud, L.
33
Berthoz, S.
42
Bigre, C. Dugré Le
42
Birkhofer, A.
47
Birmes, P.
37
Blaabjerg, H.
45
Blais-Bergeron, M.-H.
48
Blanchon, B.
29
Blanco, A. Martín
44
Blanco, C. García
29
Blom, J. D.
39
Bodeau, N.
36
Boeye, R.
30, 45
Bohus, M.
25, 26, 28, 33, 36,
38, 41, 49, 51, 55,
56, 57, 58, 59, 60
Bokhan, N.
44
Boldero, J.
27
Bolm, T.
38
Bondy, B.
54
Boomsma, D.
42
Borgmann, E.
56, 58
Borroni, S.
26
Bös, C.
48
Bosch, L. van den
27, 28,
48, 53, 55
Botella Arbona, C.
32
Bouchard, S.
48
Bouillault, G.
29
Bowles, D.
32
Braakmann, D.
47
Bragoszewska, J.
32
Brambilla, P.
31
Breton, J.-J.
36
Brodsky, B.
35
Broek, P. J. A. van den
59
Broglia, D.
45
Brokuslaus, I.
56
Brosig, I.
32
Brunner, R.
27, 36, 50, 51
Bruno, I.
35
Buchheim, A.
38, 53
Buchheim, P.
Bui, E.
Buitelaar, J. K.
Bulke, D. van den
Burnand, Y.
Busschbach, J. J. V.
Bydlowski-Aidan, S.
41, 52
37
59
36
40
40
36
C
Cailhol, L.
37, 46, 50
Calcagni, M. L.
35
Calvo Piñero, N.
30, 44
Camchong, J.
39
Camozzo, I.
45
Canalda, G.
31
Canta, G.
47
Carballedo, A.
37
Cárdenas-Morales, L.
30
Carpenter, D.
51
Carrasco, J. L.
55
Carvalho, I.
47
Casas Brugué, M.
29, 30,
31, 35, 44
Caspar, F.
33, 40
Castells, M.
44
Castellvi, P.
30
Castro-Fornieles, J.
31
Caverzasi, E.
31, 45
Cebollada, A.
31
Cecchini, M.
35
Chanen, A.
27, 33, 37, 51
Chapman, A.
59
Chinchilla, A.
31
Christina, B.-J.
30
Cimpan, D.
35
Clarkin, J.
39, 41,
48, 52, 55
Clemente, T. di
40
Clément, O.
43
Coccaro, E.
26, 37
Cohen, D.
36, 47
Coid, J.
34
Coll, J. Barrachina
47
Connemann, B.
30
Connolly, G.
37
Corcos, M.
36, 42,
46, 47, 48
Cós Milás, A. de
29
Crespo, E.
32
Cullen, K.
39
Cumming, P.
50
Curt, F.
42
Cvjetkovic-Bosnjak, M.
32
Czobor, P.
53
D
Dadasovic, J.
Dahl, A. A.
Dahme, B.
Daig, I.
Daini, S.
32
48
32
45, 49
35
DallÁsta, M.
39
Daly, I.
37
Damante, G.
31
Darker-Smith, S. M.
31, 33
Dazzi, S.
48
Degener, A.
39
Delvenne, V.
42, 47
Derom, C.
42
Deschamps, P.
35
Despland, J.-N.
33, 40
Desrosiers, L.
36
Devine, D.
59
Dewa, C.
54
Díaz-Marsá, M.
55
Dieben, K.
29
Diego-Balaguer, R. de
31
Dijke, A. van
59
Dijkhuizen, A.
38
Dimeff, L.
26, 43, 54
Distel, M.
42
Dixius, A.
47
Doering, S.
39, 42, 53
Dolan, R.
50
Domes, G.
31, 49
Dornelles, V.
37
Douniol, M.
42
Drabble, J.
32
Driessen, M.
31, 43, 49
Drobot, L.
33, 39
Düformantel, B.
60
Dugré Le Bigre, C.
36
Durán Cristobal, I.
31
Dyer, A.
34, 41, 52, 56, 58
Dziobek, I.
54
E
Ebner-Priemer, U.
32, 51, 56
Edel, M.-A.
35
Eerola, K.
39
Ehmer-von Geiso, C.
31
Eisenbeis, S.
53
Eisenhardt, K.
46
Elzinga, B.
49
Emmelkamp, P. M. G.
40
Ende, G.
26
Endrass, T.
54
Endtner, K.
53
Eriksson, J. G.
29
Esaki, K.
45
F
Fabbro, D.
Fan, J.
Farrell, J.
Fearns, N.
Feige, B.
Feinberg, G.
Feixas, G.
Feliu, A.
Fergusson, Y.
Fernando, S.
31
37, 49
43, 58
39, 44
51
26, 52
33
44
37
31, 43
Ferrer Vinardell, M.
Ferretti, V.
Fertuck, E.
Feurino, III, L.
Fidi, E.
Fink, A.
Fischer-Kern, M.
Fiselier, J.
Fladung, A.-K.
Fleischer, M.
Foelsch, P.
Fogd, D.
Fonagy, P.
Forns, M.
Fossati, A.
Fotiadou, A.
Frambati, L.
Frerich, N.
Freund, C.
Freyberger, H. J.
Friedel, R.
Frodl, T.
Fruzzetti, A.
Fuente, J. E. de la
Fuhrhans, C.
Fydrich, T.
30,
31, 35, 44
45
35
57
45
45
53
53
30, 32
31
33
53
25, 60
31
26
45
40
31
30, 45
49, 57
57
37
40, 56
31
28
38
G
Gaglia, A.
39
Galletero, J. M.
45
Gambini, F.
31
Gancedo Villegas, B.
30, 44
García Blanco, C.
29
García, M.
31
García Palacios, A.
32
García, R.
31
García Sánchez, F.
29
Garganeyeva, N.
32
Gárriz, M.
30
Gelabert, E.
30
Genova, A. di
30, 44
Gerok-Falke, K.
56
Gescher, D. M.
32
Ghahramani, M.
46
Gicquel, L.
50
Gil Rios, C.
32
Gimeno, S.
47
Giove, R.
44
Giulia, d. V.
31, 45
Gnam, W.
54
Göder, R.
56
Gomez, R.
31
Gonta, S.
45
González, E.
31
Goodman, M.
37, 38,
42, 49, 51
Gooren, T.
38
Gordon, N.
53
Goth, K.
27
Grabe, H.
49, 54
Gradillas, C.
Grassi-Oliveira, R.
Grathwol, T.
Greßing, D.
Grèzes, J.
Griepenstroh, J.
Grootens, K.
Gruenewaldt, V. von
Guelfi, J. D.
Guenot, F.
Guibauld, O.
Guilé, J.-M.
Guillen Botella, V.
Guimond, T.
Gunia, H.
Gutiérrez, F.
32
37
28, 46
59
37
43
54, 59
29
47
43
36
36
32
54
55, 60
30
H
Haake, P.
43
Habermeyer, E.
53
Habermeyer, V.
53
Haffner, J.
27
Hakamäki, S.
29
Haliburn, J.
35
Hamers, E.
40
Hamm, A. O.
57
Hänni, M.
53
Hanschek, M.
44
Hansen, J.
39
Hariri, A.
50
Harmatta, J.
43
Hartmann, D.
29
Hauenstein, K.
31
Hayakawa, M.
32
Hazlett, E. A.
38, 42
Heekeren, H.
54
Heidenreich, T.
34
Heinonen, K.
29
Heinz, A.
50
Hellhammer, D. H.
29, 36
Henning, B.
39
Hentschel, A. G.
34
Henze, R.
51
Herpertz-Dahlmann, B.
27
Herpertz, S.
38, 49
Herpertz, S. C.
25, 31, 37,
43, 49, 57
Herrmann, U.
59
Heyes, M. P.
27
Hoek, W.
39
Hoerst, M.
26
Höfling, V.
34
Hölter, T.
35
Hoppe, A.
30
Hoppe, G.
29
Horváth, K.
43
Hörz, S.
35, 41,
47, 53, 60
Höschel, K.
28
Huber, C. G.
30
Hüffmeier, J.
44
67
Huguelet, P.
Hulbert, C.
Hummelen, K. W.
Hutsebaut, J.
Huynh, C.
I
Iliopoulou, L.
Ivanoff, A.
Iwata, N.
29, 30
27
59
48
36
45
27, 28, 35
45
J
Jacob, G.
26, 33, 38, 51
Janelle, A.
47
Jeannot, M.
46, 48
Jelicic, A.
45
Jha, T.
45
Jobst, A.
47
Joergensen, C. R.
30, 45
Jokinen, J.
53
Joraschky, P.
30, 46
Jordet, H.
30
Josef B., A.
30
Joukamaa, M.
29
K
Kaasenbrood, A.
Kaby, V.
Kaess, M.
Kahl, K. G.
Kajantie, E.
Kalckreuth, C. von
Kamiya, E.
Kammer, T.
Kamphausen, S.
Kane, E.
Karch, S.
Kastouni, K.
Kathmann, N.
Katsakou, C.
Kedia, G.
Keinanen, M.
Keiper, P.
Keller, A.
Kendler, K.
Kennedy, J.
Kiefer, M.
Kienast, T.
Kilian, H.
Kilzer, K.
Kimura, H.
Kirstin, B.
Kitajima, T.
Kjoelbye, M.
Kleindienst, N.
Klett, M.
Kliem, S.
Knutson, B.
Koch, W.
68
53
29
27, 36
35
29
27
45
30
51
53
31
47
54
39, 40, 44
42
39
31
30, 46
36
26
32
28, 35, 37,
44, 50, 52
46
44
45
30
45
30, 45
36, 38,
41, 56, 57
27
34
50
31
Koenigsberg, H.
Kolla, N.
Kolly, S.
Komninou, K.
Konrad, K.
Koudela, S.
Koutras, V.
Kramer, U.
Kratzel, A.
Kraus, B.
Krause-Utz, A.
Krischer, M.
Kristensen, C.
Kröger, C.
Krüger, A.
Krüger, M.
Krylova, E.
Kumakura, Y.
Kunckler, J.-J.
Kurz, M.
Kuskowski, M.
37, 38,
42, 49
54
40
45
50
32, 51
45
33, 40
43
52
38, 49
27, 36, 47
37
34
41, 56
46
30
50
29
29
39
L
Labelle, R.
47
Lackner, N.
44
Ladenhauf, K.-H.
45
Lahti, M.
29
Lai, C.
35
Lamas, C.
36
Lammers, C.-H.
49, 58
Lang, S.
54
Lapastora de Mingo, M. P.
29
Lavilla, M.
55
Lawrence, K.
37
Lazzaretti, M.
31
Leal, I.
47
Lehmkuhl, G.
47
Lehmkuhl, U.
36
Leihener, F.
43
Leopold, S.
44, 45
Lévesque, D.
48
Lida-Pulik, H.
47
Lieb, K.
26, 29, 36,
38, 51, 57, 58
Lieb, S.
46
Limberger, M.
36
Lim, K.
39
Lin, E.
54
Linehan, M.
25, 41,
52, 55, 60
Link, A.
28, 60
Links, P.
40, 49, 54, 58
Lintonen, T.
29
Lischke, A.
49
Lisulov, R.
32
Liu, X.
37, 49
Livesley, J. W.
34
Lollo, F.
44
Lopez Villar, B.
55
Lorentzen, P.
39
Lorillard, S.
Löwe, B.
Lubbers, J.
Ludäscher, P.
Ludewig, S.
Lunacek, M.
Lynch, T.
40
31, 49
30
41, 59
52
45
53, 55
M
Madeddu, F.
44, 48
Maffei, C.
26, 35, 38, 51, 52
Magallon Neri, E.
31, 33
Maggie, R.
30
Malafosse, A.
30
Malevani, J.
32
Malmquist, E.
55
Manning, S.
28, 51
Maraffini, E.
31
Marcinko, D.
47
Marco, H.
32
Marco-Pallares, J.
31
Marissen, M.
53
Markus, R.
43
Maroco, J.
47
Marougka, S.
39, 40, 44
Martín Blanco, A.
29, 31, 44
Martinez Luna, F. R.
29
Martinis, F. de
44
Martín-Santos, R.
30
Martius, P.
35, 47
Maruottolo, C.
45
Mascaró, A.
45
Mathur, A.
37
Matic, N.
27
Mattern, M.
36
Matthies, S.
26
Mattila, A.
29
Mauchnik, J.
29, 41, 51
Max, E.
28
Mayer-Bruns, F.
28
McCutcheon, L.
33
McGee Ng, S.
34
McMain, S.
34, 54, 58
Medina Barrios, R.
29
Medzihradska, S.
43
Meier, L.
56
Meisenzahl, E.
54
Memar, M. A.
46
Memmesheimer, M.
51
Mendes, A.
47
Meyer, B.
32
Michalak, J.
34
Michela, S.
31
Milák, P.
43
Miro, A.
32
Miyahara, K.
45
Mobascher, A.
29, 36
Moeller, H.-J.
31, 54
Möhler, E.
47, 53
Mohse, M.
38
Molina López, D.
55
Moncany, A.-H.
Monreal, J. A.
Morales, L.
Morandotti, N.
Moreno, A.
Moscowitz, D.
Mrose, J.
Mulder, R.
Murat, J.
Muscionico, M.
Mussgay, L.
37
31
47
31, 45
47
49
30, 46
27
38
29, 30
51
N
Naber, D.
30
Nadort, M.
58
Namyslowska, I.
32
Narita, Y.
45
Navarro Haro, M. V.
32
Neale, M. C.
42
Nedic, A.
32
Nesseler, T.
28
Neubauer, A.
44
Neuper, C.
44
New, A. S.
36, 37, 38,
42, 49, 51
Nicastro, R.
29
Niedtfeld, I.
37
Niemelä, P.
39
Nilsonne, Å.
53
Nirestean, A.
35
Noack, R.
30, 46
Normandin, L.
48
Nyström, B.
53
O
Oasi, O.
Ochsner, K.
Oei, N.
O`Grady-Walsh, A.
Ohlendorf, P.
Oldham, J.
Olga, S. C.
Olssøn, I.
Ongarato, S.
Onorato, O.
Osmond, C.
Ozaki, N.
45
37, 49
49
37
40
26, 33, 52
29
48
39
36
29
45
P
Pabst, A.
56
Padilla, D.
47
Pallasch, B.
29
Pankok, J.
45
Pardo, J.
39
Paris, J.
49
Parzer, P.
27, 36
Pascual, J. C.
29, 31, 44, 55
Pastuszak, A.
43
Paxton, R.
34
Peiler, P.
46
Penterman, B. J. M.
59
Pepin, C.
29
Pereira, I.
47
Pérez, A.
33
Perez-Diaz, F.
42, 46, 47
Perez Sola, V.
29, 44, 55
Pérez, V.
29, 31
Peri, J. M.
30
Perroud, N.
29, 30
Pesonen, A.-K.
29
Pfeiffer, E.
36
Pham, A.
36
Pham-Scottez, A. 42, 46, 47, 50
Philipsen, A.
26, 34, 40
Pires, P.
47
Piscitelli, R.
52
Piscitelli, S.
52
Plener, P.
30
Pogarell, O.
31
Poncza, B.
44
Porr, V.
26, 52
Pose Cabarcos, A.
29
Poustka, F.
27
Prada, P.
29
Prass, C.
43
Prehn, K.
31, 38
Preisig, M.
40
Preißler, S.
54
Preti, E.
44, 48
Preuss, U.
54
Priebe, K.
41, 56
Priebe, S.
39, 40, 44
Prill, T.
51
Prossin, A. R.
42
Prunas, A.
29, 44, 48
Prusik, M.
32
Pürstner, P.
44
Q
Quilty, L.
34
R
Radovanovic, M.
45
Rahn, E.
59
Räikkönen, K.
29
Ramati, A.
45
Ramos Ferraz, L.
30
Ramos, V.
47
Rampi, E.
45
Randenborgh, A. van
44
Rathjen, U.
43
Rauch, A.
56
Reichborn-Kjennerud, T.
36
Reicherzer, M.
31, 46
Reidy, J.
32
Reinelt, E.
58
Reinhard, I.
51
Reiske, S.
52
Reiss, N.
43, 58
Reitz, S.
59
Renneberg, B.
49, 53, 54, 56
Rentrop, M.
35, 47, 59
Rentzsch, K.
43
Resch, F.
27, 36, 47
Retz, W.
26
Revah-Levy, A.
48
Ribas, J.
31, 44
Richardson, R.
35
Rich, E.
38
Richter, C.
46
Richter, H.
34
Rinne, T.
28, 34, 42, 60
Ritter, K.
54
Robin, M.
36, 42
Robinson, R. J.
35
Rodriguez-Fornells, A.
31
Rodriguez Gomez-Carreño, C.29
Rodriguez, S.
30
Roepke, S.
58
Röhl, M.
31
Romine, A.
39
Ronningstam, E.
60
Roos, J.
27
Röpke, S. 32, 34, 41, 49, 54, 58
Rossier, J.
30
Rossi, G.
29
Roten, Y. de
33, 40
Rücker, G.
58
Rüddel, H.
51
Rufat, M. J.
29, 47
Ruíz de la Hermosa, L.
29
Rüsch, N.
51
Russell, J.
49
Russino, E.
39
Rüter, A.
41
Ruttmann, A.
32
Rylander, G.
53
S
Sabourin, S.
48
Sala, M.
31
Salamin, V.
43
Salbach-Andrae, H.
36
Samson, A.
37
Samuelsson, M.
53
Sánchez, D.
44
Sánchez, E.
44
Sánchez, F. García
29
Sánchez-Mora, C.
31
San Emeterio, M.
44
Santangelo, P.
32, 51
Sartori, M.
40
Savio, G.
45
Schaaff, N.
31
Schaletzky, R.
46
Scheel, C.
51
Schehr, K.
28
Schenkel, T.
60
Schlagenhauf, F.
50
Schlosser, N.
31, 43
Schmahl, C.
25, 26, 30, 37,
38, 41, 43, 49,
51, 54, 56, 57, 59
69
Schmeck, K.
33
Schmid, C.
46
Schmidt Do Prado-Lima, P. A. 37
Schmitt-Eliassen, J.
30
Schmitt, L.
37
Schneider, F.
28, 33
Schönfeldt-Lecuona, C.
30
Schoofs, J.
29
Schott, B.
29, 50
Schotte, C.
36
Schröder-Abé, M.
49, 58
Schroeder, K.
30
Schulte-Herbrueggen, O.
41
Schulz, C.
39
Schulze, L.
31, 49
Schürmann, B.
54
Schütz, A.
43, 49, 58
Schwarze, C. E.
29, 36
Schweiger, U.
25, 31, 34,
38, 43, 52
Sebastian, A.
38
Secret-Bobolakis, I.
50
Seeck-Hirschner, M.
56
Semke, V.
47
Seppanen, S.
39
Sevecke, K.
27, 36
Shaw, I.
43
Shinhel, K.
47
Sieswerda, S.
50
Siever, L.
26, 37, 38,
42, 49, 54
Silja, K.-V.
30
Silk, K.
42, 57
Sipos, V.
46
Skodol, A. E.
25, 28
Slotema, C.
39
Smits, M.
48
Sobanski, E.
38
Sobrino Cabra, O.
29
Sola, V. Pérez
44
Soldatovic-Stajic, B.
32
Soler, J.
29, 31, 44, 55
Solzbacher, S.
51
Sommer, I.
39
Soto, A.
31
Soto Lumbreras, A.
44
Speranza, M. 36, 42, 46, 47, 48
Spitzer, C.
31, 41, 49, 54
Spodenkiewicz, M.
48
Spreeuwenberg, M. D.
40
Spretz, D.
53, 56
Staebler, K.
49
Stankard, P.
32
Stanley, B.
35
Stecher-Mohr, J.
38, 53
Steil, R.
34, 41,
51, 52, 56
Steinert, T.
47
Stephan, P.
47
Stiglmayr, C.
38, 41, 53,
54, 55, 56
70
Stijnen, T.
Stippel, A.
Stoffers, J.
Stopsack, M.
Strauß, E.
Strehlow, G.
Ströhle, G.
Subirà, S.
Sud, N.
Sud, S.
Sulzer, S.
Swales, M.
Szyf, M.
40
47
58
54
53, 56
35
34
30
33
33
46
52
25, 43
T
Taieb, O.
Tatsch, K.
Teixidó, M.
Terfehr, K.
Thurn, C.
Tiana, T.
Tilly, C.
Timmer, A.
Tollenaar, M.
Torgersen, S.
Torrubia Beltri, R.
Toso, K. del
Tragesser, S.
Trull, T.
Tschacher, W.
Tschöke, S.
Tuescher, O.
Turner, B.
Tüscher, O.
Tyrer, P.
48
31
44
31
36
29, 44
60
58
49
36
30
31
35, 54
42, 51
53
47
51
59
26, 38, 51
25, 28, 35
U
Uhlmann, C.
Unoka, Z.
Unterrainer, H.-F.
Uppenkamp, S.
47
53
44, 45
31
V
Valdeperez, A.
44
Vállez, M.
30
Vartiainen, H.
29
Vasic, V.
32
Vater, A.
41, 49, 58
Vega Moreno, D. de la
31, 44
Verdaguer, E.
47
Verheul, R.
34, 40
Verkes, R. J.
59
Verzhybok, H.
47
Vidovich, G. de
31, 45
Viitanen, P.
29
Villani, S.
45
Vinardell, M. Ferrer
29
Viñas, F.
29
Vink, J.
42
Vogel, F.
43
Vohs, K.
31
Völlm, B. A.
Vonau, M.
Vreeswijk, M. van
58
34
38, 56
W
Wahlbeck, K.
Wallner-Liebmann, S.
Walter, M.
Wawrzyniak, E.
Weerdt, M. de
Weinberg, I.
Weissgerber, S.
Weiß, R.
Wekenmann, S.
Welke, T.
Whalley, B.
Wiklander, M.
Wilczek, A.
Willemsen, G.
Wilson, S.
Wingenfeld, K.
Witkowska, M.
Wnuk, S.
Wöckel, L.
Wohl, B.
Wolf, I.
Wolf, M.
Wolf, O. T.
Wrase, J.
Wuolijoki, T.
Wüstenberg, T.
29
44, 45
60
56
29
60
58
58
46
56
55
53
53
42
35
31, 49
32
54
27
46, 56
49
46
31, 49
50
29
50
Y
Yazdani Fard, M.
Yen, S.
Yeomans, F.
Ystrom, E.
46
36
26, 42
36
Z
Zaragoza, P.
Zecca, G.
Zechowski, C.
Zepf, F. D.
Zetzsche, T.
Zimmer, J.
Zimmermann, P.
47
30
32, 39
27
54
56
38
We organize your success
CPO HANSER SERVICE is specialized in the field of Conference, Event,
Destination Management and Association Management and has been
organizing events of any size throughout Germany and worldwide for
more than 25 years.
CONFERENCE – EVENT – DESTINATION – ASSOCIATION MANAGEMENT
We offer you:
■ the best congress organization
■ state-of-the-art online solutions
■ electronic abstract handling
■ CME accreditation handling
■ effective congress technology
■ sponsoring and exhibition acquisition and management
■ finance management
■ professional tax solutions
■ creative event programs
■ inhouse graphic design
BERLIN
Paulsborner Str. 44
phone +49-30-300 669 0
fax +49-30-305 73 91
email [email protected]
HAMBURG
Zum Ehrenhain 34
22885 Barsbüttel, Germany
phone +49-40-670 882 0
fax +49-40-670 32 83
FRANKFURT AM MAIN
Julius-Reiber-Str. 15 a
64293 Darmstadt, Germany
phone +49-61 51-428 368-0
fax +49-61 51-428 368-9
www.cpo-hanser.de
I N
I
N
C O N
O N
G R
O U
P
a
Wegweiser durch den Kongress
Sehr geehrte deutschsprachige Teilnehmer,
wir begrüßen Sie und alle Teilnehmer aus über 40 Ländern herzlich in Berlin.
Auf Grund der großen internationalen Beteiligung ist die offizielle Kongress
sprache Englisch. Wir haben jedoch Sorge getragen, dass auch Teilnehmer,
die ausschließlich Deutsch sprechen, von diesem Kongress profitieren:
GAlle Plenar-Vorträge (Plenary Lectures, jeweils von 11.00 bis 12.30 Uhr)
und die Eröffnungsveranstaltung am (Donnerstag, 1. Juli, 13.30 – 15.00 Uhr,
werden simultan übersetzt.
Symposien
GEine Auswahl an Symposien wird in deutscher Sprache gehalten. Diese sind
im Programm gekennzeichnet: . Einige Symposien werden simultan über
setzt:
Poster
GDie Postersitzung P009 wird ausschließlich in Deutsch präsentiert.
Round Table
GDas Betroffenen-Diskussionsforum / Round Table (Samstag, 3. Juli, 9:00 bis
10:30 Uhr) wird ebenfalls deutschsprachig gehalten.
Abendveranstaltungen
GWir laden Sie sehr herzlich ein!
Get Together
GDonnerstag, den 1. Juli im Foyer des bcc
Congress Dinner im traditionellen Berliner Lokal „Nolle“
GBei Buffet und Getränken werden die „Singing Shrinks“ für Unterhaltung
sorgen. Eintrittskarten sind am Registrierungscounter sowie am Abend im
Restaurant für EUR 48 erhältlich.
Join the
2nd International Congress on
a September 2012, The Netherlands

1st International Congress on Borderline Personality Disorder

Transcription

Documents pareils

DBT - CIP

Vereins-Flyer - Borderline

Jackie B. - ein Leben in Extremen Jackie B.

BORDERLINE-SYNDROM

Persönlichkeitstests unter der Lupe

Plakat norway.today - Freilichtspiele Schwäbisch Hall

Vor 2000:

Welcher Mann hat schon gern eine graue Frau?